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BARTONELLA HENSELAE INHIBITS CELLULAR APOPTOTIC REGULATORS TO 
ENSURE SURVIVAL 
By 
 
JEFFERY TODD PARKER 
 
Under the Direction of Barbara R. Baumstark 
 
ABSTRACT 
 
Human pathogens survive anti-pathogen host immune assault by either circumventing or 
evading the host immune response. Bartonella henselae, an intracellular pathogen previously 
shown to disrupt intrinsic apoptotic messengers to enhance its survival, exploits multiple facets 
of the cellular apoptotic mechanisms.   
Cellular pathways affected by apoptotic processes were assessed using real-time reverse-
transcriptase-polymerase-chain-reaction (rRT-PCR) to measure the effect of B. henselae on cell 
regulator gene expression (TRADD, FADD, caspase-8 and caspase-3), caspase activity, DNA 
cell cycle analysis, cell regulator protein expression and overall cell viability and morphology. 
The presence of B. henselae suppresses overall gene expression for TRADD and FADD and it 
dramatically suppresses ceramide-induced TRADD and FADD gene expression. The presence of 
B. henselae has a noticeable effect on ceramide-induced caspase-8 and caspase-3 gene 
expression. Only caspase-3 enzymatic activity was ceramide-induced and likewise supressed by 
the presence of B. henselae, whereas caspase-6 and caspase-8 were unaffected and equivalent to 
controls. The presence of B. henselae inhibits ceramide-induced DNA fragmentation, maintains 
overall cell morphology and enhances host cell viability. Lastly, B. henselae inhibits the time-
dependant ceramide-induction of TRADD protein and suppresses ubiquitous FADD protein 
expression.  
We demonstrated that B. henselae inhibits apoptotic induction in a systematic manner 
following exogenous apoptotic induction. B. henselae protection of microvascular endothelial 
cells from apoptosis induction begins at the modulation of cell surface receptor-dependent 
signaling. B. henselae minimizes, but does not completely abrogate, the cytotoxic effect of the 
apoptogenic shingolipid ceramide on human microvascular endothelial cells (CDC.EU.HMEC-
1).  
 Broadening our understanding of the sequence of cell regulator suppression events by 
intracellular pathogens will provide insight into disease manifestation. Further, understanding 
how infected cells initiate and conclude apoptosis will open new avenues into the study of 
disease treatment. 
INDEX WORDS: Bartonella henselae, Apoptosis, Ceramide, TRADD, FADD, Caspase, Real-
time RT-PCR 
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CHAPTER 1 
GENERAL INTRODUCTION 
 
Overview 
 Cell death is an essential process in the growth and maintenance of all multicellular 
organisms. Cells are constantly being replaced as they age or become damaged. Since the human 
body typically produces about 10 billion new cells each day, it must have some way to rid itself 
of senescent, functionally impaired, or otherwise unwanted cells. One way to accomplish this is 
through apoptosis. 
 Apoptosis is a well-ordered process of programmed cell death. Cells undergoing 
apoptosis show a distinct set of morphological changes, including shrinking of the cytoplasm, 
condensation of chromatin in the nucleus, and membrane blebbing. The last stages of apoptosis 
are accompanied by the disintegration of the cell into small vesicles called apoptotic bodies. 
Apoptotic processes play a number of beneficial roles during the life cycle of the organism, 
including the removal of infected and neoplastic cells, and the elimination of superfluous cells 
during differentiation and development. Apoptotic processes have also been implicated in the 
cellular destruction associated with a number of disease states, including Parkinson’s Disease 
(Schulz 2008), Alzheimer’s Disease (Dickson 2004), and AIDS (de St Groth and Landay 2008). 
 The highly structured mechanisms underlying apoptotic processes can be distinguished 
from necrosis, a form of death resulting from direct injury to the cell. Necrosis involves the 
release of degradative lysosomal enzymes into the cytoplasm, where they cause massive 
destruction of cellular components. Cell lysis then ensues, resulting in the release of harmful 
chemicals into the proximal extracellular environment. This in turn induces an inflammatory 
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response, precipitating the destruction of surrounding tissues.  In contrast, cellular debris 
accumulating in the late stages of apoptosis is rapidly ingested by tissue macrophages in a 
manner that does not induce the inflammatory response (Moreira and Barcinski, 2004). The 
signal for phagocytic ingestion of apoptotic bodies is the translocation of phosphatidyl serine 
(PS) from the inner to the outer leaflet of the plasma membrane (Figure 1). The process by which 
PS is moved to the external surface of the cell is not fully understood, but its role as a marker 
triggering phagocytic digestion allows apoptotic bodies to be eliminated without eliciting the 
inflammatory responses that cause damage to nearby cells (van England et al., 1998). 
 
Apoptosis Pathways of Induction 
 There are two general mechanisms of apoptotic induction. The extrinsic pathway, as its 
name implies, is triggered by a signal from outside the cell. Specific signaling ligands initiate the 
apoptotic sequence by interacting with a transmembrane receptor located on the cell surface. 
Trimerization of this receptor in response to ligand binding then precipitates a cascade of events 
that leads to the sequential activation of several cysteine-aspartate-specific proteases (caspases). 
Activated caspases degrade cellular components directly or indirectly through their proteolytic 
activation of other cellular proteases. Induction of the caspase cascade results in the eventual 
death of the cell (Salvesen and Dixit 1999). The intrinsic pathway is induced by internal 
stressors, such as DNA damage, heat shock, or by products of the extrinsic pathway.  The 
intrinsic pathway involves the permeabilization of mitochondrial membranes and the resulting 
release of mitochrondrial proteins into the cytoplasm, where they set in motion a caspase cascade 
that eventually merges with that of the extrinsic pathway (Giacca 2005). 
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Figure 1 Phosphotidylserine Translocation.  Translocation of phosphotidyl serine (PS) is an 
early indicator of apoptosis. Following apoptosis induction, PS translocates to the outer 
membrane and marks the cell for ingestion by phagocytic cells. 
 
The Extrinsic Pathway 
 The initial stages of extrinsic induction have been well characterized, and are mediated by 
the action of several tumor necrosis factors (TNF), or “death receptors”. Tumor necrosis factor 
(TNF) receptors are members of a superfamily of membrane-spanning proteins that includes 
TNF-receptor-1 (TNFR1), TNF-receptor-2 (TNFR2) and Fas (Ware, 2003). Activation of the 
TNF receptors is believed to occur when a trimerized ligand such as FasL or TNF-α induces the 
trimerization of three TNF receptor monomers at the cell surface (Dempsey et al., 2003). TNF 
receptor proteins contain a highly conserved 80-amino-acid region that is localized to the 
cytoplasmic side of the membrane (Thorburn, 2004). This region of the protein is referred to as 
the “death domain” (DD).  Through interactions between their death domains, trimerized TNF 
receptors cluster together in lipid rafts (ceramide-rich regions of the plasma membrane) to form a 
signal transduction complex (Grassme et al., 2003; Ruvuolo, 2003). The receptor trimers attract 
specific adaptor proteins that bind to the receptors through their own DD sequences (Walsh et 
Assymteric distribution of 
phosphatidyl serine  
(lumen side only) 
Symmetric distribution of 
phosphatidylserine  
(both sides) 
Apoptosis  
induced 
Cell Membrane Lipid 
Bilayer 
Phosphatidylserine 
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al., 2003). Adaptor proteins in turn recruit procaspase-8 (an “initiator” caspase) to the TNF-
receptor complex, acting directly or indirectly through a second adaptor protein. Binding by 
procaspase-8 to the adaptor protein occurs at a region of homology shared by the two proteins 
called the Death Effector Domain (DED).  Association of receptor, adaptor(s), and procaspase-8 
produces a complex on the membrane called the Death Inducing Signaling Complex (DISC; 
Ashkenazi and Dixit, 1998).  
 The process of DISC formation can be illustrated by the interactions between TNFR1 and 
its adaptor proteins. Following binding of the ligand to the receptor, TNFR1 trimers form a 
complex with the adaptor molecule TRADD (TNF-receptor-associated death domain) through 
interactions between the death domains of the two proteins. TRADD in turn recruits a second 
adaptor molecule, FADD (Fas-associated death domain), which also binds to TRADD through 
DD interactions (Green, 2003). The DED region of FADD then interacts with the homologous 
region of procaspase-8; (Thorburn et al., 2003) to form the DISC (Figure 2). Procaspase-8 exists 
within this complex as a dimer and undergoes a process of self-activation. Activated caspase-8 
subsequently recruits and activates an “executioner” caspase (caspase-3), and this process sets in 
motion a cascade that ultimately results in the digestion of about 100 proteins (Creagh et al., 
2003).  
 
Caspase-8 Activation 
 Caspases function as “messengers” by relaying apoptotic signals from adaptor proteins to 
cellular target proteins. To prevent unscheduled cell suicide, each caspase is translated as a 
zymogen containing a pro-domain and a catalytically active domain (Green, 2003; Boatright and 
Salvesen, 2003). Early studies on the mechanism of caspase-8 activation revealed that the two 
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procaspase-8 molecules recruited to the DISC are able to undergo cross-proteolysis in trans, with 
one digesting the other (Zimmerman and Green, 2001). This caused investigators to equate 
activation with autoproteolysis, and led them to propose that proteolytic cleavage is an essential 
component of the caspase-8 activation process (Shi, 2002).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Formation of the TNF-receptor Death-inducing-signaling-complex (DISC). The 
trimeric ligand trimerizes the TNF receptor (A). The trimeric receptor recruits the primary 
adaptor protein, TRADD (B). The primary adaptor recruits the secondary adaptor protein, FADD. 
Interaction of adaptors is through the Death Domain (DD) of the adaptor proteins (C). The 
Death-Effector-Domain (DED) of the secondary adaptor protein interacts with the DED of the 
recruited initiator caspase, procaspase-8 (D). 
 
However, the results of more recent studies suggest that proteolysis is not in itself necessary for 
the generation of caspase-8 activity (Thorburn 2004). This conclusion is based on investigations 
into the role played by naturally occurring inactive caspase-8-like molecules in the regulation of 
DD
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DD
DD
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DED
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Figure 2:  DISC formation at TNFR1.  
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death-receptor induced apoptosis. These regulatory molecules are called cellular FLICE-like-
inhibitory proteins, or c-FLIP. FLICE stands for FADD-like-interleukin-converting-enzyme, the 
name previously assigned to caspase-8 (Day et al., 2006).  .  
 c-FLIP proteins can exist in two isoforms, a long form (c-FLIP-L) and a short form (c-
FLIP-S). c-FLIP-L contains two DED domains plus a region homologous to the catalytic domain 
of caspase-8 (Kataoka 2005). c-FLIP-S also contains two DED domains, but lacks the caspase-8 
catalytic domain region. c-FLIP-L can dimerize with caspase-8, but is not an active protease 
because it contains several sequence differences that affect the catalytic domain of the protein 
(Longley et al., 2006). 
 By interacting through their DED regions with adaptor molecules such as FADD, c-FLIP 
proteins compete with procaspase-8 for binding at the DISC (Figure 3). Based on this 
observation, c-FLIP proteins were initially believed to act solely as inhibitors of apoptosis. 
Subsequent evidence, however, suggested that under certain circumstances the recruitment of c-
FLIP-L to the DISC can actually promote apoptosis by activating caspase-8 (Sohn et al., 2006). 
Recent studies have demonstrated that the formation of a heterodimer between c-FLIP-L and 
procaspase-8 is enough to induce caspase-8 activity, even though c-FLIP-L is unable to catalyze 
the cross-proteolysis of its partner. This has led investigators to conclude that caspase-8 is 
enzymatically active in its unprocessed form. Processing may stabilize the caspase-8 dimer, but is 
neither necessary nor sufficient for catalytic activation (Boatright and Salvesen 2003; Salvesen 
and Dixit 1999; Zimmerman and Green 2001).  
 The demonstration that dimerization alone is sufficient for caspase-8 activation has raised 
questions as to the role of processing in caspase-8 activity. Recent evidence indicates that 
caspase-8 is recruited to the cytosolic complex of TRADD and FADD (Micheau and Tschopp, 
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2003). The caspase-8 dimer is capable of self activation by cleavage of internal residues. Within 
the cytosol the processed caspase-8 is available to interact with substrates in close proximity 
(Harper et al., 2003).  
 
(A).     (B). 
 
 
 
 
 
 
 
 
 
Figure 3. c-FLIP L Is a Caspase-8 Antagonist and/or Activator. The long form of cellular 
FLICE-like inhibitory protein c-FLIP L interacts with FADD and Caspase-8. (A). c-FLIP L 
dimerizes with caspase-8 (proform), inducing its activation. (B). c-FLIP L competes with 
caspase-8 for FADD death-effector-domain (DED). 
 
Activation of Other Caspases 
 Following its activation, caspase-8 cleaves caspase-3, setting off a cascade of proteolytic 
events that result in the activation of several downstream caspases. Once activated, 
“executioners” caspases such as caspase-3 (Feng, Y. et al., 2005), caspase-6 (MacLachlan and 
El-Deiry, 2002) and caspase-7 (Xia, Y. et al., 2007; Slee et. al., 2001) cleave key cellular 
components, thereby precipitating cell death. Each executioner caspase can exist as an inactive 
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dimer in its zymogen form. The executioner caspases reside primarily in the cell cytosol. 
Caspase-3 is the most abundant caspase in the cytosol, and acts as an executioner for both 
extrinsic and intrinsic pathways (Chickova et al., 2004). Caspase-3 cleaves caspase-6 and poly-
ADP-ribosyl polymerase as well as other cellular proteins. Activation of these targets ultimately 
leads to the cleavage of lamin proteins and the fragmentation of nuclear DNA (Hirata et al., 
1998). 
 
The Intrinsic Pathway 
 As mentioned previously, internal cellular stress such as DNA damage or oxidative stress 
can act as a trigger for apoptosis. The response to internal stress is mediated by the intrinsic 
pathway. Intrinsic induction of apoptosis leads to an increased permeability of the mitochondrial 
outer membrane, which results in the release of cytochrome c and other mitochondrial proteins 
that trigger a caspase cascade. Regulation of membrane permeability is achieved by members of 
a large protein superfamily called Bcl-2, derived from B-Cell Lymphoma, the cell lineage from 
which it was originally identified (Yang et al., 1997). Included within the Bcl-2 superfamily are 
proteins that stimulate apoptosis (pro-apoptotic proteins) and those that suppress it (anti-
apoptotic proteins; Cory and Adams, 2002). All Bcl-2 family members share one or more of four 
BH (Bcl-2 Homology) domains that promote protein-protein interactions and are required for 
protein function. Anti-apoptotic proteins contain all four domains (BH1 – BH4), while pro-
apoptotic proteins contain from one to three domains (Cory et al., 2003).  
Induction of the intrinsic pathway begins with a disruption of the balance between pro- 
and anti-apoptotic factors. The two primary anti-apoptotic proteins, Bcl-2 and Bcl-XL, are located 
in the outer membrane of the mitochondria. Two additional Bcl-2 family members, Bax (Bcl-2 
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associated X protein) and Bak (Bcl-2 homologous antagonist/killer protein), also reside in the 
mitochondrial membrane (Figure 4). Based on their resemblance to bacterial pore forming 
channel proteins, Bax and Bak are believed to be involved in production of the pores through 
which mitochondrial components are leaked into the cytoplasm (Desagher et al., 1999). Thus, 
they play a pro-apoptotic role within the cell. There are also several cytoplasmic pro-apoptotic 
proteins that act as sensors of cellular stress. These proteins typically contain only the BH-3 
homology domain, and therefore are sometimes referred to as BH-3-only proteins. If they are 
activated by apoptotic signals, they travel to the surface of the mitochondria where they interact 
with membrane-associated Bcl-2 family members (Ashkenazi, 2008).   
The BH3-only proteins can be divided further into three subgroups. One group, 
represented by proteins such as Bim (Bcl-2 interacting mediator of cell death), can bind directly 
to the pro-apoptotic proteins Bax and Bak, activating them to produce pores in the membrane. 
The second group, represented by proteins such as Bik (Bcl-2 interacting killer protein) and Bad 
(Bcl-2 associated death promoter), are believed to exert their effect primarily by binding to anti-
apoptotic proteins such as Bcl-2 and Bcl-XL (Bcl-2 extra-long protein) (Ashkenazi, 2008).  In 
this way, they displace other pro-apoptotic proteins that might be bound to the anti-apoptotic 
proteins, thereby freeing proteins such as Bax and Bak to oligomerize with each other and form 
pores. The third group, represented by Bid (BH3 Interacting Domain death agonist), can induce 
pore formation through direct binding to Bak/Bax or through binding to the anti-apoptotic 
proteins (Goping et al., 1998). The mechanism of action of the pro-apoptotic protein Bid (Figure 
5) provides a well-documented example of the steps leading to induction of the intrinsic pathway, 
and illustrates how the apoptotic switch depends on a delicate balance between the pro- and anti-
apoptotic proteins at the mitochondrial membrane (Lessene et al., 2008).  
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Under non-apoptotic conditions, Bid is located in the cytosol in its inactive form (Tang et 
al., 2000). In response to cellular stress, however, Bid can be activated by caspase-8, which 
cleaves it into a truncated form known as tBid (Ogretum and Hannun, 2004). tBid then migrates 
to the surface of the mitochondrion, where it interacts directly with Bak, causing the protein to 
undergo a conformational change that induces Bax/Bak pore formation (Cory et al., 2003). In 
addition to its effect on Bak, tBid can also interact with anti-apoptotic proteins such as BclXL. If 
the anti-apoptotic proteins are in excess, they can bind to tBid, thereby sequestering it so that it 
cannot interact with and activate Bak; conversely, if tBid is in excess, it can inactivate anti-
apoptotic proteins and directly activate Bak simultaneously. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Intrinsic Apoptosis Pathway. The intrinsic pathway demonstrates the interaction of 
the caspase cascade and the bcl-2 proteins. Mitochondrial proteins interplay in the formation of 
the apoptosome leading to activation of executioner caspase-3. Image adapted from 
www.proteinlounge.com 
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It has been reported (Grinberg et al., 2002), that a mutant Bid that lacks a functional BH3 
domain is still able to induce cyctochrome c release and apoptosis in the absence of direct 
interactions with either Bak or the Bcl-2 anti-apoptotic proteins. To explain these observations, 
the investigators proposed the tBid forms homo-oligomers through a BH3-independent 
mechanism to create pores in the mitochondrial membrane. Thus, it is possible that Bid plays 
multiple roles in the apoptotic process.  
Cytochrome c, a heme-binding protein that is loosely associated with the inner 
mitochondrial membrane, is an integral component of the mitochondrial electron transport chain.  
 
 
 
Figure 5. Mechanism of Action of Bid. Bid is activated by caspase-8 cleavage to generate the 
truncated (t-Bid) form. tBid can interact with both anti-apoptotic proteins (Bcl-XL) or pro-
apoptotic proteins (Bax/Bak). Excess of Bcl-XL will lead to sequestering of tBid. Excess of tBid 
leads to inactivation of Bcl-XL and activation of Bax/Bak. 
 
Bid                                                                      tBid   
Cellular stress 
Caspase 8 
Bcl-XL                            Bax/Bak   
 Prevents activity of      Activates pore 
Pro-apoptotic factors         formation 
Release of Cytochrome c 
12 
With the destruction of mitochondrial membrane integrity following an apoptotic stimulus, 
however, cytochrome c is quickly released into the cell cytosol (Kluck et al., 1997; Yang et al., 
1997), where it binds to and activates APAF-1 (apoptosis protease activating factor-1), a receptor 
protein located at the outer mitochondrial membrane. The APAF-1/cytochrome c complex then 
associates with dATP to form a complex called the apoptosome (Wang, 2001). The caspase 
recruitment domain (CARD) of APAF-1 recruits caspase-9 to the apoptosome complex 
(Rodriguez and Lazebnik, 1999). Apoptosome-bound caspase-9 initiates the activation of 
terminal effector proteins (e.g., caspase-6) through the cleavage and activation of other 
executioner caspases (caspase-3 and -7) (Tao et al., 1998). Through its proteolytic activation of 
caspase-3, caspase-9 initiates the cleavage of multiple cellular targets, which ultimately results in 
an orderly disintegration of the cell (Wang, 2001; Nakazawa et al., 2003). However, 
mitochondrial induced apoptosis does not necessarily require caspase-9 (King, 2005). 
 
Ceramide and Ceramide Signaling 
 Ceramides are lipid molecules consisting of sphingosine and a fatty acid. They constitute 
part of the structure of sphingomyelin, one of the major components of the lipid bilayer, and as a 
consequence are present in high amounts in the plasma membrane. The classic cell membrane 
model, originally depicted by Singer (Singer and Nicholson, 1972), proposes a random 
distribution of lipids and proteins in the cell membrane. However, recent studies indicate that 
the lipid distribution in the cellular membrane is anything but random. Until recently, ceramides 
were believed to function predominantly as structural components in the membrane.  In the past 
few years, however, a number of studies have revealed that these compounds also play a role in 
cell signaling, participating in several processes, including cell differentiation, cellular 
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senescence, and the growth of cancer cells (Browne and London, 1998). Moreover, it is 
becoming increasingly evident that ceramides play a pivotal role in apoptosis (Davis et al., 
2006). 
 It has been shown that clustering of Fas and members of the TNF receptor superfamily 
triggers the conversion of sphingomyelin into ceramide (Gulbins and Li, 2006). The newly 
generated ceramide then becomes a major component of the lipid rafts that serve as the anchor 
points for the association of TNF receptors and other proteins with pro-caspase-8 to form the 
DISC complex used in the extrinsic apoptotic pathway. Recent studies also demonstrate that 
ceramide is essential for the formation of these lipid rafts. In doing so it serves as an essential 
signaling component for the aggregation of receptor death domains (Gulbins et al., 2000; 
Grassme et al., 2001). Ceramide also plays a role in the intrinsic apoptotic pathway by 
activating the kinase suppressor of Ras (KSR).  Activation of KSR initiates a phosphorylation 
cascade that ultimately inhibits Akt, a kinase whose substrates include the Bcl-2 pro-apoptotic 
protein Bad (Datta et al., 1997; Schubert et al., 2000). Phosphorylation by Akt converts Bad into 
its inactive form. Thus, the indirect inhibition of Akt by ceramide leads to the accumulation of 
unphosphorylated, active Bad at the mitochondrial membrane, and thereby promotes cell death 
(Basu et al., 1998).  
Ceramides are classified by the length of their fatty acid chains. Natural ceramides 
typically have fatty acid chains of ~16-carbon atoms. Cultured cells are permeable to exogenous 
short-chain (two to six carbons) ceramides, but are not permeable to longer carbon chain 
molecules. Still, ceramides greater than six carbons can translocate between the leaflets of the 
cells plasma membrane. Exogenously supplied ceramides mimic their natural analogues to 
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induce anti-proliferative responses, cell-cycle arrest, differentiation, and apoptosis (Obeid et al., 
1993). 
Exogenously added C2-ceramides have been reported to increase the permeability of 
mitochondrial membranes. However, it can also induce NFκB, which subsequently induces a 
number of genes responsible for cell survival (Ruvulo, 2001). In cells of cancer origin, C2-
ceramides lead to transient caspase-3 activation following 24 hours of ceramide treatment (Fillet 
et al., 2003). The mode and severity of cellular response to ceramide are cell type specific. 
 
Bartonella and Host Cell Survival 
 Bartonella henselae is the causative agent of Cat-Scratch Disease (CSD), an illness 
characterized by low-grade fever, malaise, and swelling of the lymph nodes (Emmons et al., 
1976).  The bacterium is usually transmitted through the bite or scratch of an infected cat or 
kitten. Symptoms appear between one and two weeks after infection (Bass et al., 1997). In many 
patients, a small cutaneous lesion is noted at the site of the bite or scratch a few days after the 
injury (Slater et al., 1993). B. henselae infects endothelial, epithelial, erythrocyte and 
macrophage cells in cats and humans (Minnick and Anderson, 2000; Kempf et al., 2005). In 
immunocompetent individuals, CSD is typically a self-limiting disease, lasting from six to 12 
weeks. In contrast, immunocompromised individuals such as AIDS patients can be persistently 
infected by B. henselae. Persistent B. henselae infection can trigger endothelial cell proliferation, 
resulting in Bacillary Angiomatosis (BA). Patients with BA have multiple vasculoproliferative 
lesions on their skin. Vascular tumors can also appear in response to organ infection, a process 
known as Bacillary Peliosis (BP). The bacterial factor(s) responsible for this proliferation have 
not been fully characterized, although they are known to be proteinaceous and require bacterial 
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synthesis following infection (Maeno et al., 1999; Dehio 2003). Upon infection of endothelial 
cells, the bacteria induce the formation of an adhesion-molecule-rich cell membrane protrusion 
called an invasome (Dehio 1999).  
The formation of the invasome is an actin-dependent and microtubulin-independent 
process. Aggregated bacteria are trapped in the actin and phosphotyrosine-rich tips of the 
protrusion and drawn into the cell (Figure 6). The tips of the invasome are also enriched in caps 
of intracellular adhesion molecule-1 (ICAM-1) and other adhesion molecules (Dehio, 2003). 
Gene expression of most adhesion molecules, including ICAM-1, VCAM-1 and ELAM-1 
molecules is regulated by the nuclear factor NF-κB (Clifton et al.1998; True et al., 2000). 
Vascular endothelial cells either ubiquitously express or are induced to express adhesion 
molecules following cytokine treatment (Ades et al., 1992). In addition to adhesion molecules, 
NF-κB regulates cell proliferation factors including vascular endothelial growth factor, VEGF 
(Kirby 2004; Kempf et al., 2001). 
 Enhanced expression of host-encoded growth factors via a paracrine loop has been 
demonstrated following B. henselae infection of several cell types. The presence of the bacteria is 
not necessary for either enhanced endothelial cell proliferation or enhanced growth factor 
expression but direct contact between B. henselae and endothelial host cells does potentiate an 
enhanced proliferative effect (Fuhrmann et al., 2001). Growth factor expression is not sustained 
indefinitely following intracellular B. henselae infection (Kempf et al., 2002).  
 
Bartonella and Apoptosis Suppression  
 Obligate intracellular pathogens, particularly viruses, often ensure their survival by either 
promoting host cell proliferation or by preventing the induction of programmed cell death (Lax 
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and Thomas, 2002; Mehock et al., 1998; Hentschel et al., 2000; Saini et al., 1999). It has been 
shown previously that B. henselae infection upregulates cell surface adhesion molecule 
production and suppresses activity of both initiator and executioner caspases (Kirby and 
Nekorchuk, 2002). The upregulation of vascular cell endothelial growth factor (VEGF) and 
secretion of other apoptosis inhibitory proteins is considered to be the principal anti-apoptotic 
mechanism used by Bartonella (Kempf et al., 2005).  Recently, Bartonella encoded anti-
apoptotic substrates have been described (Schmid et al., 2004; Schmid et al., 2006). Our studies 
were designed to investigate the multifaceted manner by which B. henselae exerts an anti-
apoptotic effect by modifying both molecular expression and protein expression/activation of 
both extrinsic and intrinsic apoptosis modulators. 
 
  
Figure 6. Invasome. The “invasome” is characterized by membrane protrusions which entrap an 
aggregate of bacteria. The invasome facilitates B. henselae invasion of endothelial cells through 
adhesion molecule rich membrane protrusions (reproduced with permission, Cristoph Dehio). 
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Summary 
 The mechanisms whereby B. henselae establishes and maintains a successful infection 
have not been fully characterized. However, it has been demonstrated that neither host cell 
growth nor a paracrine loop of endogenous growth factors are the sole mechanisms for ensuring 
B. henselae intracellular survival (Anderson, 2001; Resto-Ruiz et al., 2002). The reports that B. 
henselae affects the expression of genes that are known to be involved in cell death suggest that 
this bacterium may use an additional survival mechanism: the prevention of apoptotic processes 
that would ultimately lead to the death of its host cell. Activation of cell growth and suppression 
of apoptosis are two seemingly opposite pathways with the same net effect. This study addresses 
the observations that B. henselae ensure its survival by processes that extend beyond a simple 
manipulation of cell proliferation. Rather, B. henselae preserves its safe haven by inhibiting the 
initial intrinsic apoptotic pathway and, further, preventing the induction of executioner caspases 
targeted by the apoptogenic agent C2-ceramide. The cellular factors inhibited by B. henselae 
provide a comprehensive restraint on the intrinsic apoptosis pathway modulators.  
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CHAPTER 2 
BARTONELLA HENSELAE INHIBITION OF APOPTOSIS MODULATORS 
 
Introduction 
Intracellular pathogens and tumor cells enhance their ability to survive by circumventing 
host apoptosis. Tumor cells accomplish this by inducing the over-expression of anti-apoptotic 
proteins, such as Bcl-2 (Apakama et al., 1996). However, pathogens first mitigate the immune 
assault against them before successfully infecting the competent host cells. The tropism of B. 
henselae for endothelial cells is an intriguing evolutionary adaptation due to 1.) the presence of 
Gram negative bacterial LPS on B. henselae, 2.) the endothelial cell role in excreting TNF-α 
following exposure to bacterial LPS and 3.) the endothelial cell expression of NF-κB genes 
following paracrine-loop exposure to TNF-α (Dehio, 2001; Kyong-Bok et al., 1998; Imaizumi et 
al., 2000). B. henselae seems to exploit all of these features to permit the tropism for an 
intracellular safe haven in microvascular endothelial cells. 
 To ensure chronic intracellular infection, B. henselae is capable of inhibiting apoptosis. 
Our study was designed to investigate the ability of B. henselae to inhibit apoptosis following 
direct apoptogenic challenge. A variety of apoptogenic agents were screened for their ability to 
induce apoptosis. Among these agents were camptothecin, staurosporine, C2-ceramide, ricin 
toxin and abrin toxin. The mode of action of these agents spans protein kinase activation, 
inhibition of protein kinase DNA binding, inhibition of DNA packaging enzymes and inhibition 
of ribosomal activity. We chose C2-ceramide not only because it was capable of inducing dose 
dependent apoptosis, but also because it mimics the mechanism of LPS induced inflammatory 
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pathways. The addition of C2-ceramide alters the membrane bilayer to induce the formation of 
lipid rafts.  
Table 1. Apoptogenic Agents. 
  Mode of action Effect on HMEC-1 cells 
 
TNF-α 
 
Induces extrinsic apoptosis pathway, 
causes release of in vivo ceramide 
Ineffective with HMEC-1 
 
C2-ceramide 
 
Increases protein kinase activity         
        
Concentration and time-
dependent morphological 
effect 
 
 
Staurosporine 
 
Inhibition of protein kinase ATP binding 
 
Required high 
concentration before 
effective 
 
Camptothecin 
 
Quinoline alkaloid inhibits DNA  
topoisomerase I 
 
Low concentration 
obliterated cells, media 
cloudy 
 
ET-18 
(etoposide) 
Topoisomerase II inhibitor           
 
Low concentration 
obliterated cells, media 
cloudy 
 
Ricin toxin 
 
Depurination of eukaryotic ribosomal  
sarcin-ricin loop 
Effective at low 
confluency and low serum  
 
Abrin toxin 
 
Depurination of eukaryotic ribosomal  
sarcin-ricin loop 
Effective at low 
confluency and low serum  
 
Serum 
starvation 
 
Varied: G0/G1 cycle arrest, 
downregulation of  
ERK2 activity 
 
≤5% serum has "serum 
starvation effect" 
 
A variety of apoptogenic agents were tested for their ability to induce apoptosis. Mechanism of 
apoptosis for agents tested was varied. Agents were tested on uninfected cells for 4 hours 
incubated at 35oC at 95% humidity.  
 
Lipid raft formation provides a mechanism for intrinsic apoptosis pathway receptors to 
cross link, thereby initiating the intrinsic apoptosis pathway. The presence of B. henselae 
interferes with the C2-ceramide stimulated expression of intrinsic pathway proteins such as TNF-
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associated death domain (TRADD) and Fas-associated death domain (FADD) inhibiting the 
initiating stage of apoptosis induction. Further, the presence of intracellular B. henselae inhibits 
C2-ceramide stimulated expression of caspase proteins and caspase enzymatic activity. Lastly, the 
presence of B. henselae inhibits DNA fragmentation and the protective effect attributed to the 
bacteria is visible by changes in gross cellular morphology.   
 
Materials and Methods 
Western Blot 
HMEC-1 cells were lysed using PBS-TDS (0.01M PBS with 1% Triton X-100, 0.5% 
sodium deoxycholate, 0.1% SDS, 1% protease inhibitor cocktail (Pierce, Rockford, IL; Burnette, 
1980). Twenty micrograms of cell lysates were mixed 1:5 with 5X Loading Buffer (Bio-Rad, 
Richmond, CA). Cell lysates were loaded using an SDS-PAGE precast (12% resolving gel, 4% 
stacking gel) minigel system (Bio-Rad, Richmond CA). Gels were run at 20 mA following 
dilution of 10X Tris/Glycine/SDS Buffer (Bio-Rad, Richmond, CA). Proteins were transferred 
onto Immuno-Blot PVDF Membrane (Bio-Rad, Richmond, CA) at 250 mA for 1 hour.  
Blot membranes were blocked using 10X Blocking Agent (Bio-Rad, Richmond, CA) in 
TBS overnight at 4oC. PVDF membranes were incubated with primary Rabbit anti-FADD 
antibody (Santa Cruz) at 1:1000 in Blocking Buffer for 1 hour at room temperature while shaking 
gently. Blots were washed 3x 10 minutes in Wash Buffer (TBS supplemented with 0.1% Tween 
20). Blots were incubated with phosphatase-labeled anti-Mouse IgG (H+L) secondary antibody 
(KPL, Gaithersburg, MD) at 1:10,000 in Blocking Buffer for 1 hour at room temperature while 
shaking gently. Blots were washed 3x 10 minutes in Wash Buffer while shaking. Blots were 
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developed by incubating for 10 minutes with PhosphaGLO Reserve AP Substrate (KPL, 
Gaithersburg, MD). Excess substrate was drained and blots were inserted into a plastic sheet 
cover. Blots were visualized using a Bio-Rad documentation System. 
Bacterial Culture  
Bartonella henselae 882-str was cultured on Brain Heart Infusion (BHI) agar 
supplemented with 5% rabbit blood and 50 μg/mL streptomycin (Invitrogen, Carlsbad, CA). To 
obtain pure cultures of B. henselae, bacterial cultures were streaked for isolation and allowed to 
grow for 3 days at 37 oC and 5% CO2. Cultures used for infection were prepared by streaking B. 
henselae onto a plate of BHI with 5% rabbit blood and 50 μg/mL streptomycin (Lee and Falkow, 
1998).  
Cultures were grown for 3 days post-inoculation to ensure that log-phase bacteria were 
used for all experiments. The zone of inoculum was scraped with a 10 μL loop and resuspended 
in BHI broth. Bacterial cells were resuspended to an O.D.600 of 0.5, an optical density that 
corresponds to approximately 1×109 cfu/mL. The concentration of bacteria was determined by 
triplicate plate counts of serial bacteria dilutions, as described previously (Kirby and Nekorchuk, 
2002). 
Cell Culture  
CDC.HMEC-1 (HMEC-1) cells were obtained by Material Transfer Agreement (F.J. 
Candal, E.W. Ades, CDC, Atlanta, GA; T. Lawley, Emory University, Atlanta, GA.). HMEC-1 
endothelial cells were grown at 37 oC and 5% CO2 using MCDB-131 (GIBCO BRL) media 
supplemented with 15% fetal bovine serum (Hyclone, Ogden, UT), 25 μg/mL streptomycin and 
1% L-glutamine (Invitrogen, Carlsbad, CA). HMEC-1 cells were seeded at 1.5×105 cells/mL for 
both stock subcultures and experimental cultures. HMEC-1 cells were grown for 3 days to 70%+ 
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confluency prior to experimental use. Cells were subcultured every 7 days or as needed. For 
optimal performance and stability, HMEC-1 cells were used at passages T16 to T25.  
 
Chemicals and Antibodies  
C2-ceramide (N-acetyl-D-erythrosphingosine) was dissolved in absolute ethanol at a 
concentration of 20 mM (Avanti Polar Lipids, Alabaster, AL). Murine anti-human TRADD and 
FADD were obtained from BD/Pharmingen (San Diego, CA). Secondary 488 conjugated goat 
anti-mouse IgG was obtained from Molecular Probes (Eugene, OR). Staurosporine and 
camptothecin were obtained from Sigma (St. Louis, MO). RNAase H was obtained from 
Epicentre (Madison, WI).  
Ricin and abrin toxin were prepared from whole beans. One gram of beans was macerated 
to generate pulp mass and expressed toxin “mother liquor.” PBS (0.01M, pH 7.2-7.4) was added 
to provide 1 mL of aqueous phase. Total material was centrifuged for 3 minutes at 3000 xg at 
25oC. The aqueous phase was decanted and centrifuged again for 3 minutes at 3000 xg at 25oC. 
The respective toxins were semi-quantified using CDC LRN immunoassays for the detection of 
ricin or abrin toxin compared to a known toxin standard. 
Intracellular Infection with B. henselae and Ceramide Treatment  
HMEC-1 cells were grown to 70%+ confluency prior to infection. B. henselae bacteria 
were harvested and resuspended at 1×107 cfu/mL in serum-free MCDB-131 media (Invitrogen, 
Carlsbad, CA). An absorbance of 0.5 at 600 nm yields 1×109 cells/mL (McCord et al., 2005). 
The cell culture medium was replaced with reduced serum (3% serum) media prior to B. 
henselae infection. HMEC-1 cells were infected at an MOI of 10 by adding 100 μL of a 1×109 
cfu/mL bacterial suspension to HMEC-1 cells cultures approximately 70%+ confluent. HMEC-1 
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cultures were grown in 6-well Costar culture plates.  B. henselae-infected cells were allowed to 
incubate overnight and then media replaced with MCDB-131 supplemented with 15% FBS for 
the remainder of the 36 hours at 37 oC and 5% CO2 (Liberto et al., 2003). C2-ceramide was added 
to a total concentration of 20 μM to both B. henselae-infected and uninfected endothelial cells. 
Uninfected and untreated cells were used as experimental controls. 
Endothelial Cell Viability Assay  
Cell viability was determined by Trypan Blue (Invitrogen, Carlsbad, CA) exclusion (Bird 
and Forrester, 1981). Cells were harvested by collecting trypsinized cells following standard 
trypsinization procedures. Trypsinized cells were briefly centrifuged for 3 minutes at 100 xg at 4 
oC. The supernatant from centrifuged cells was carefully aspirated to remove cellular debris. 
Collected cells were resuspended in a minimal volume of 100 μL. Trypan Blue was added at a 
1:1 ratio with resuspended cells and viability was determined by a standard protocol using a Seitz 
cell counting chamber (Sigma, St. Louis MO). 
Flow Cytometric Intracellular Protein Analysis  
HMEC-1 endothelial cells were infected and treated with ceramide as described here. 
Cells were harvested by gentle agitation with 100 μM glass beads (Corning Glass, Corning, NY) 
as described here. Harvested cells were washed 2x with 0.01M PBS, pH 7.4, and pelleted by 
centrifugation at 100 xg for 3 minutes. Pelleted cells were resuspended and fixed by adding 10% 
EM-grade formalin (Polyscience, Warrington, PA) in 0.01M PBS, pH 7.4, to a final 
concentration of 1.5% formaldehyde. Cells were incubated in fixative for 10 minutes at 4oC. 
Fixed cells were washed 2x with 0.01M PBS, pH 7.4, and pelleted by centrifugation at 100 xg for 
3 minutes. Cells were then resuspended and permeabilized in 1X Perm II solution (BD, San Jose, 
CA) in 0.01M PBS, pH 7.4 (Invitrogen, Carlsbad, CA) for 10 minutes at 4 oC (Belloc et al., 
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2000). Cells were washed 2x with FACS Wash Buffer (0.01M PBS, pH 7.4 (Invitrogen, 
Carlsbad, CA) supplemented with 2% human AB+ serum (Irvine Scientific, Irvine, CA.) + 
0.01% NaN3). Cells were pretreated with excess unlabeled anti-TRADD or FADD antibodies 
(BD, San Jose) for 1 hour at 4 oC and washed 2x with FACS Wash.  
Cells were stained using 0.5 μg/sample of anti-TRADD (BD, San Jose, CA), 0.5 μg of 
anti-FADD (BD, San Jose, CA) in 0.01M PBS, pH 7.4 at 4oC overnight. Cells were washed 2x 
with FACS Wash and centrifuged at 100 xg. Secondary Alexa 647 goat anti-mouse antibodies 
(Molecular Probes, Eugene OR) were used at a working dilution of 1:5,000. Samples were 
analyzed on a FACSCaliber cytometer (BD, San Jose CA), calibrated daily with Calibrite beads 
(BD, San Jose) supplied with lasers operating at 488 and 633 nm (Krutzik and Nolans, 2003) 
Data were acquired using the FL4 channel excited at 633 nm and 668 emission.  
Caspase Enzymatic Activity Assay  
Samples were analyzed for activity of caspase-3, 6 and 8 using TrupointTM Caspase 
Assays (Perkin-Elmer, Boston, MA), according to the manufacturers’ protocol. Briefly, cells 
were washed in the well 2x with physiological saline and lysed using a 1:10 dilution of 10X 
Lysis Buffer. Cells were homogenized by rapid pipetting and collected into 1.7 mL eppendorf 
tube. The caspase sample wells consist of 10 μL caspase-DTT Buffer, 5 μL (800 nmol/L) caspase 
substrate and 5 μL cell lysate. Background wells consist of 15 μL caspase-DTT Buffer and 5 μL 
caspase substrate (Karvinen et al., 2002). Lysates and caspase substrates were incubated at 37oC, 
95% relative humidity for a minimum of 2 hours prior to reading. Caspase assays were read using 
a Victor3 plate fluorometer at 615 nm according to the manufacturers’ protocol (Wallac, Turku, 
Finland).  
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Multicaspase Fluorescent Assay 
To a 100 μL aliquot of cells (1x105/mL), 4 μL of 20X SR-VAD-FMK (Millipore/Guava) 
reagent were added, and to each sample or control tube was mixed by gentle vortexing and 
incubated for 1 hour at 37°C in 5% CO2 incubator. The cells were resuspended once during the 
incubation period. Approximately 1 mL of 1X Apoptosis Wash Buffer (Millipore/Guava) was 
added to each tube, vortexed and centrifuged at 300 to 400xg for 5 minutes to pellet the cells. 
The supernatant was removed and the cell pellet was retained. The cells were washed twice more 
as described. Each cell pellet was resuspended in 100 μL of 1X Apoptosis Wash Buffer 
(Millipore/Guava). Approximately 50 μL of stained cells were air dried on glass slides. Slides 
were examined directly using a Nikon fluorescent microscope with a 565 nm excitation and 
615nm emission filter 
Flow Cytometric DNA Cell Cycle Analysis  
Cell supernatants were collected and pelleted by centrifugation at 100 xg for 3 minutes. 
Pelleted cells were added to harvested cells described below. Cell monolayers were washed 2x 
with 0.01M PBS, pH 7.4 (Invitrogen, Carlsbad, CA) prior to harvesting. Cells were harvested 
from culture plates by gentle agitation with 100 μM glass beads (Corning Glass, Corning, NY). 
HMEC-1 cells were prepared for ethanol fixation by washing 2x with excess 0.01M PBS, pH 7.4 
(Invitrogen, Carlsbad, CA) and centrifuged for 3 minutes at 100 xg. Cells were fixed by the 
addition of 0.5 mL 70% ethanol (Pharmco, Brookfield, CT) in sterile deionized water 
(Mediatech, Richmond VA).  
Ethanol fixed cells were washed 2x with excess 0.01M PBS, pH 7.4 (GIBCO/BRL, 
Grand Island NY) and centrifuged for 3 minutes at 100 xg. Following fixation, cells were 
resuspended in 200 μL of 0.01M PBS, pH 7.4 (Invitrogen, Carlsbad, CA) with 2 μg/mL RNAse 
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A (Epicentre, Madison, WI). Cells were incubated for 30 minutes at 37 oC, washed 2x with 
excess 0.01M PBS, pH 7.4, and subsequently resuspended at approximately 1×106 cells/mL in 
0.01M PBS, pH 7.4, containing 5 μg/mL propidium iodide (PI, Sigma, St. Louis, MO.). DNA 
cell cycle analysis was performed on a FACSCAliber (Becton-Dickinson, San Jose, CA). DNA 
cell cycle data were assessed by log range FL-2 height for PI staining (Abraham et al., 2003). 
Statistics  
The data presented herein are the means± S.D. of three independent experiments with 
experimental samples performed in triplicate. Statistical significance was determined using the 
Student’s “two-tailed” t-test. A P value of <0.05 was considered significant. 
 
Results 
Analysis of FADD by Western Blot  
Western blot analysis of Fas-associated Death Domain (FADD) was conducted to 
determine whether B. henselae altered FADD protein expression. By two hours post-infection, 
the levels of FADD are undetectable (Figure 7). From these observations, we conclude that there 
is a significant and rapid decline in FADD protein expression during the course of B. henselae-
infection relative to their uninfected counterparts.  
Apoptogenic Agents 
Apoptogenic agents were tested for their ability to alter cell viability following 3 hours’ 
treatment of HMEC-1 endothelial cells. Apoptogenic agents were serially diluted and cell 
viability determined using Trypan Blue exclusion for HMEC-1 cells grown at 4oC and 95% 
humidity. Percent viability is presented in Figure 8. Among the apoptogenic agents tested, only 
C2-ceramide was cytotoxic in a titratable dose-dependent manner. Further, several of the other  
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agents tested were cytotoxic, but did not produce the distinguishable morphological effects on 
the endothelial cells that are characteristic of apoptosis (data not shown). For these reasons, C2-
ceramide was the apoptotic agent of choice for all subsequent experiments involving the 
induction of apoptosis.  
Cellular Morphology under Apoptotic Conditions  
To determine the response of cells infected with B. henselae to signals inducing 
apoptosis, we compared the effect of infection on HMEC-1 cells that were treated with ceramide 
for varying periods of time. Prior to ceramide treatment, uninfected and B. henselae-infected cells  
Figure 7. FADD Western Blot. HMEC-1 cells were incubated with B. henselae for 1 hr at 
37oC. Growth media was added and cells were harvested at 1 and 2 hour post-infection 
timepoints. Control cells were harvested at timepoint of 2 hour post-infection identical 
manner in the absence of B. henselae.  
MW   Ctrl     1 hr      2 hr   
30.6 kDa 
17 kDa 
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Figure 8. Cytotoxic Effect of Apoptogenic Agents. Commercially available apoptogenic agents 
were titrated using dilutions of 100 μM stock (A). Ricin and Abrin toxin were prepared from 
natural source. Concentrations were determined by LRN immunoassay reactivity compared to 
standards (B). HMEC-1 cells were treated with apoptogenic agents for 3 hours. Viability was 
assessed using Trypan Blue exclusion. 
 
B 
A 
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both produce a confluent monolayer (Figure 9A and 9B). Some cell rounding is apparent in the 
infected culture, which we ascribe to an overgrowth of the cells. Little change in gross 
morphology is observed for both uninfected (Cer) and infected (B + C) cells following two hours 
of ceramide treatment (Figure 9C and 9D). Uninfected cells demonstrate a higher refractive 
index, but overall the effect on the cell monolayer is minimal for both cultures. A higher 
magnification does reveal some remarkable differences between infected and uninfected cells 
after two hours of ceramide treatment, however. Uninfected ceramide-treated cells exhibit 
cytoplasmic membrane blebbing (Figure 10A), a classic characteristic of early apoptosis events 
(Green, 2003).  B. henselae-infected cells treated with ceramide for the same amount of time 
exhibit no cytoplasmic membrane blebbing (Figure 10B).  
After four hours of treatment with ceramide, uninfected cells began to show pronounced 
rounding of the cells and sloughing of cells from the monolayer, characteristics that become 
more apparent at six hours of exposure (Figure 11A and 11C). During this same time period, 
ceramide treatment has little visible effect on the appearance of the B. henselae-infected culture 
(Figure 11B and 11D). By eight hours of treatment, the uninfected culture exhibits a pronounced 
loss of monolayer integrity (Figure 12A), while the B. henselae-infected culture exhibits modest 
rounding of the cells and sloughing of the monolayer (Figure 12B). Following 12 hours of 
ceramide exposure the uninfected cells have lost nearly all adherent properties and nearly half of 
the B. henselae-infected cells are rounding (Figure 12C and 12D). During this same time period, 
ceramide treatment has little visible effect on the appearance of the B. henselae-infected culture 
(Figure 11B and 11D).  
 
30 
Cell Viability under Conditions Inducing Apoptosis.  
The uptake of the vital dye Trypan Blue is associated with a loss of nuclear membrane 
integrity, and is thus considered to be a reliable gross indicator of cell viability. Figure 13 
illustrates the changes in cellular viability following ceramide treatment of both B. henselae-
infected (B+C) and uninfected (Cer) endothelial cells, as compared to controls that are not 
exposed to ceramide. Ceramide exposure results in a steady decline in viability for both infected 
and uninfected cells relative to the untreated controls; however, the decrease in viability is much 
more pronounced in the uninfected culture, suggesting that B. henselae infection is providing a 
protective effect against cell death. 
Intracellular Expression of TRADD and FADD  
Previous results (Figure 7) indicated that the levels of FADD in cells infected by B. 
henselae are significantly reduced in comparison to their uninfected counterparts. To determine 
the concentrations of TRADD and FADD in infected and uninfected cells under apoptotic 
conditions, flow cytometric analysis was conducted on cells that had been visualized by 
treatment with anti-TRADD and anti-FADD antibodies followed by incubation with a secondary 
goat anti-mouse antibody. Following thirty minutes of ceramide treatment, TRADD producing 
cells are minimal in both uninfected and infected cells (13% and 13.2% of the total cells, 
respectively, Figure 14A and B). Following one hour ceramide treatment, TRADD-producing 
cells remain low in the infected sample (14.9%, Figure 14C) but have begun to show an increase 
in the uninfected cells (23.1% of total cells, Figure 14D). TRADD protein production spikes for 
uninfected cells at 2 hours (75.94%, Figure 15A) and is still elevated at 3 hours (69.04%, Figure 
15C) after ceramide treatment 
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Figure 9. Cell Morphology—Controls and Two-hour Ceramide Treatment. Changes in cell 
morphology with ceramide treatment. Uninfected of B. henselae-infected cells were exposed to 
20 μM C2-ceramide for varying periods of time. A. Uninfected control cells prior to ceramide 
exposure. B. B. henselae-infected control cells prior to ceramide exposure. C. Uninfected cells 
after 2 hour exposure to ceramide. D. B. henselae-infected cells after 2 hour exposure. Figures 
are representative of multiple independent experiments (n=3). After four hours of treatment with 
ceramide, uninfected cells began to show pronounced rounding of the cells and sloughing of cells 
from the monolayer, characteristics that become more apparent at six hours of exposure (Figure 
11A and 11C). 
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Figure 10. Classic Morphology of Early Apoptosis Event. Enlarged view of 2 hour 20 μM C2-
ceramide treatment. A. Uninfected cells after 2 hour exposure. Cytoplasmic blebbing is 
highlighted in picture inset (red arrows) as compared to no blebbing (blue arrows). B. B. 
henselae-infected cells after 2 hour exposure view after two hour ceramide exposure.  
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Figure 11. Cell Morphology—Four- and Six-hour Ceramide Treatment. Change in cell 
morphology with ceramide treatment. Uninfected of B. henselae-infected cells were exposed to 
20 μM C2-ceramide for varying periods of time. A. Uninfected cells after 4 hour exposure to 
ceramide. B. B. henselae-infected cells after 4 hour exposure. C. Uninfected cells after six hour 
exposure to ceramide. D. B. henselae-infected cells after 6 hour exposure. Figures are 
representative of multiple independent experiments (n=3). 
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Figure 12. Cell Morphology—Eight- and Twelve-hour Ceramide Treatment. Change in cell 
morphology following ceramide treatment. Uninfected of B. henselae-infected cells were 
exposed to 20 μM C2-ceramide for varying periods of time. A. Uninfected cells after 8 hour 
exposure to ceramide. B. B. henselae-infected cells after 8 hour exposure. C. Uninfected cells 
after 12 hour exposure to ceramide. D. B. henselae-infected cells after 12 hour exposure. Figures 
are representative of multiple independent experiments (n=3). 
 
Among infected cells the proportion producing TRADD is only marginally enhanced at 2 hours 
(28.70%; Figure 15B) and remains low at 3 hours (22.30%, Figure 15D). The proportion of 
TRADD-positive cells in the uninfected sample has reached a plateau following 4 hours 
ceramide treatment (69.81%, Figure 16A), while TRADD production in the infected cells is still 
seen in only a small proportion of infected cells (16.13%, Figure 16B).  
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Figure 13. Cell Viability by Trypan Blue Exclusion. Cell counts were determined in        
triplicate. Uninfected cells treated with ceramide (Cer), Bartonella henselae-infected cells treated 
with ceramide (B+C), and normal control cells (Ctrl) were assessed for cellular viability by 
Trypan blue exclusion. Mock experimental controls for B+C and Cer were 69.16±4.67% and 
65.04±1.41%. Graphs are representative of multiple independent experiments (n=3). 
 
 Thus, B. henselae infection is associated with a reduction in TRADD production under 
conditions favoring apoptosis. Like TRADD, FADD is produced in more uninfected cells treated 
with ceramide than in their B. henselae-infected counterparts. Even at thirty minutes of ceramide 
treatment, the proportion of cells producing FADD in the uninfected cell population (60.7%; 
Figure 17A) is significantly higher than that seen in the infected sample (40.2%; Figure 17B). 
The numbers of FADD- producing cells in the uninfected sample increase further at one hour of 
ceramide treatment (75.1%; Figure 17C), while FADD production is waning in the infected 
sample (32%; Figure 17D) at the same time point.  Over the next three hours, the proportion of 
FADD-producing cells in the uninfected sample remains high (70% at 2 hours, Figure 18A; 64% 
at 3 hours, Figure 18C), and 81% at 4 hours (Figure 19A) of ceramide treatment). During the 
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same time period, the levels remain fairly static in the infected cell population, decreasing 
slightly after 4 hours (30.3% at 2 hours (Figure 18B, 30.8% at 3 hours (Figure 18D), and 24.7% 
at 4 hours, Figure 19B). Thus, as with TRADD, infection by B. henselae is correlated with lower 
levels of FADD following the induction of apoptosis. 
Inhibition of Caspase Activity in B. henselae Infected Cells  
The effect of B. henselae infection on caspase activity was initially measured using the 
Trupoint assay system (Perkin-Elmer). Controls using both normal control cells and untreated B. 
henselae-infected cells were used for comparison. The results (Figure 20) reveal that the 
enzymatic activity for caspase-8 and caspase-6 are enhanced in both B. henselae-infected and 
ceramide-treated cells, as compared to their uninfected counterparts. Caspase-6 is significantly 
increased in B+C cells, as compared to Cer cells, only following prolonged ceramide treatment. 
Caspase-3 enzymatic activity, as seen in Figure 20A, is enhanced in Cer cells, as compared to 
B+C cells or control cells. Enzymatic activity for caspase-3 rapidly increases following 1 to 4 
hours of ceramide treatment.  
Multicaspase Fluorescent Peptide Assay for Detection of Caspase Activity  
The multicaspase fluorescent peptide assay makes use of a peptide substrate that can be 
cleaved by caspases to yield fluorescent products. Although the assay does not differentiate 
between a spectrum of caspases (caspase-2, -3, -6, -7, -8, and -10), it does provide a picture of the 
overall levels of caspase activity, and hence the apoptotic condition of the cell (Slee et al., 1999). 
Use of this assay indicates that B. henselae-infected cells demonstrate a rapid induction of 
caspase activity following 2 and 3 hours of ceramide treatment (Figure 21A and 21C).  
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Figure 14. TRADD Protein Expression Analysis by Flow Cytometry—Thirty minute and 
One-hour Ceramide Treatment. TRADD protein expression for Cer and B+C cells following 
30 minutes (A and B, respectively) and 1 hour (C and D, respectively) following ceramide 
treatment. TRADD protein expression is baseline for both Cer cells (13.01%) and B+C cells 
(13.19%) following 30 minutes ceramide treatment. Following 1 hour ceramide treatment, 
TRADD protein expression increases for Cer cells (23.12%, C) as compared to B+C cells 
(14.89%, D). Figures are representative of two independent experiments (n=2). 
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Figure 15. TRADD Protein Expression Analysis by Flow Cytometry—Two- and Three- 
hour Ceramide Treatment. TRADD protein expression for Cer and B+C cells following 2 (A 
and B, respectively) and 3 hour (C and D, respectively) ceramide treatment. TRADD protein 
expression is enhanced for Cer cells following 2 hour ceramide (75.94%, A) as compared to B+C 
cells (26.70%, B). Following 3 hour ceramide treatment, TRADD protein expression decreases 
for Cer cells (69.04%, C) and is relatively unchanged for B+C cells (22.30%, D). Figures are 
representative of two independent experiments (n=2). 
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Figure 16. TRADD Protein Expression Analysis by Flow Cytometry—Four-hour Ceramide 
Treatment. TRADD protein expression is still enhanced for Cer cells following 4 hours 
ceramide treatment (69.81%, A) as compared to slight decrease in B+C cells (16.13%, B). 
Figures are representative of two independent experiments (n=2). 
 
Multicaspase activation in these cells wanes following 4 hours of ceramide treatment, and 
continues to decline following 6 hours of treatment (Figure 21E and G). Uninfected cells also 
exhibit a rapid overall induction of caspase activity between 2 and 3 hours of ceramide treatment 
(Figure 22A and 22C), but unlike their infected counterparts, they continue to demonstrate 
induced caspase activity, as indicated by the maintenance of high fluorescence levels extending 
after 4 and 6 hours of treatment (Figure 22E and 22G). Taken together, these results suggest that 
B. henselae suppresses overall caspase induction under apoptotic conditions.  
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Figure 17. FADD Protein Expression Analysis by Flow Cytometry—Thirty Minute and 
One-hour Ceramide Treatment. FADD protein expression for B+C and Cer cells following 30 
minutes (A and B, respectively) and 1 hour (C and D, respectively), following ceramide treatment. 
FADD protein expression is enhanced for Cer cells following 30 minutes ceramide (60.65%, A) 
as compared to B+C cells (40.19%, B). Following 1 hour ceramide treatment, FADD protein 
expression increases for Cer cells (75.13, C) as compared to a decrease in FADD protein 
expression for B+C cells (32.09%, D). Figures are representative of two independent experiments 
(n=2). 
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Figure 18. FADD Protein Expression Analysis by Flow Cytometry—Two- and Three-hour 
Ceramide Treatment. FADD protein expression for B+C and Cer cells, following 2 hour (A 
and B, respectively) and 3 hour (C and D, respectively) ceramide treatment. FADD protein 
expression is enhanced for Cer cells following 2 hour ceramide (69.83%, A) as compared to B+C 
cells (30.31%, B). Following 3 hour ceramide treatment, FADD protein expression decreases for 
Cer cells (64.19%, C), while FADD protein expression remained unchanged for B+C cells 
(30.76%, D). Figures are representative of two independent experiments (n=2). 
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Figure 19. FADD Expression Protein Analysis by Flow Cytometry—Four-hour Ceramide 
Treatment. FADD protein expression for both Cer and B+C cells, following 4 hour (A and B, 
respectively) ceramide treatment. FADD protein expression is enhanced for Cer cells following 4 
hour ceramide (81.70%, A) and decreases for B+C cells (24.70%, B). Figures are representative 
of two independent experiments (n=2). 
 
Effect of B. henselae infection on Ceramide-induced DNA Fragmentation   
Flow cytometry was conducted in order to assess the effect of infection on DNA 
fragmentation, which is an indicator of apoptotic conditions. The fluorescent intercalating dye 
propidium iodide (PI) was used for cell staining. The DNA cell cycle was determined by FL-2 
height (FL2-H) on a log scale: actively growing cells are expected to sort at positions 
corresponding to G1 (1X DNA) through S and G2 (2X DNA), while cells in a resting state, G1/G0, 
or those undergoing DNA fragmentation, sub G1/G0, should exhibit correspondingly less 
fluorescence than their active counterparts (Elzbieta et al., 1998). Untreated B. henselae-infected 
and uninfected cells demonstrate a typical DNA histogram distribution (Figure 27A and B 
respectively), with cells distributed between G1, S and G2.  
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Figure 20. Caspase Activity Assay. Caspase-3 enzymatic activity is suppressed for B+C cells as 
compared to Cer treated cells (A). Both caspase-6 (A) and caspase-8 (C) enzymatic activity are 
enhanced for B+C cells as compared to Cer cells. Enhanced enzymatic activity of caspase-6 and 
caspase-8 for B+C cells is not over that of control (Ctrl) cells. However, caspase-6 and-8 activity 
is similar to that of untreated B. henselae infected controls (B. alone). Significant enhanced 
expression above controls is denoted by asterick (p<0.05). Values represent mean ±S.D of 
multiple independent experiments (n=3).
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Figure 21. Multicaspase Fluorescent Substrate: B+C Cells. The cell permeable caspase 
substrate is reactive to cleavage by caspase-2, 3, -8, -9, -10. Enhanced fluorescence indicates 
increasing levels of overall caspase activity. Caspase fluorescence is baseline following 2 hours 
(A), enhanced following 4 hours (E) and wanes following 6 hour ceramide treatment (G), for B. 
henselae infected cells (B+C). Light micrographs demonstrate the presence and position of 
endothelial cells. 
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Figure 22. Multicaspase Fluorescent Substrate: Cer Cells. The cell permeable caspase 
substrate is reactive to cleavage by caspase-3, -8, -9, -10. Caspase fluorescence is at baseline 
following 2hours (A), but intensifying following 3 hours (C) and 4 hours (E) of ceramide 
treatment. Fluorescence remains steady following 6 hours ceramide treatment (G) for uninfected 
and ceramide treated cells (Cer). Light micrographs demonstrate the presence and position of 
endothelial cells. 
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Figure 23. DNA Cell Cycle Analysis. DNA content and cell cycle is determined by PI staining 
of ethanol fixed cells. B.henselae alone control cells (A) has a small, but unsubstantial sub-
G1/G0 population. Typical G1/G0, S, G2M histogram is observed in ceramide negative control 
sample (B). Neither B+C nor Cer cells demonstrate significant sub-G1/G0 population for 1 hour 
(C and D, respectively) and 3 hour (E and F, respectively) ceramide treatment. Six hour 
ceramide-treated cells (H) demonstrate a remarkable sub-G1/G0 population as compared to 6 hr 
B+C cells (G). Following 8 hour ceramide B+C cells demonstrate a minimal sub-G1/G0 
population (I) as compared to a breakdown of standard DNA cell cycle profile (J). Likewise, at 
no other timepoint is there a substantial sub-G1/G0 population. Histograms are representative of 
multiple independent experiments (n=3). 
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There is a small population of sub-G1/G0 cells in the infected sample, but the levels are 
not substantial. Similar patterns are seen following one and 3 hours’ exposure to ceramide for 
both infected (Figure 27C and 27E, respectively) and uninfected cells (Figure 27D and 27F, 
respectively). Following six hours of ceramide treatment, the infected cells continue to be 
distributed among the G1, S and G2 cycles (Figure 27G), but a large sub-G1/G0 population, 
indicative of apoptosis, is clearly evident in the uninfected sample (Figure 27H).  Only after 8 
hours of ceramide treatment do any of the infected cells appear in the sub-G1/G0 stage, and their 
numbers are minimal. In contrast, by this time, the uninfected cell population reveals a distinct 
loss of the normal DNA cell cycle profile.  
 
Discussion 
Gram-negative Bacterial Infection and Apoptotic Response 
Gram negative bacteria such as B. henselae are cloaked in lipopolysaccharide (LPS), and 
the presence of Gram-negative bacterial LPS initiates the host anti-bacterial immune response 
(Hu et al., 1998; Dauphinee and Karsan, 2006). The Gram-negative bacterial LPS are responsible 
for the host pyrogenic response that occurs during bacterial sepsis (Hotchkiss et al., 2002; 
Rudiger et al., 2008), and LPS alone is a known apoptosis agonist (Hull et al., 2002). Other 
studies have shown that bacterial LPS induce apoptosis in HMEC-1 cells, provided there is an 
additional agonist (Kyong-Bok et al., 1998). The presence of bacterial LPS causes microvascular 
endothelial cells to excrete cellular TNF-α (Karsan et al., 1996).  Excretion of TNF-α, in turn 
promotes infiltration of immune system cells, particularly neutrophils (Bartee et al., 2008). 
Likewise, TNF-α specifically upregulates NF-κB genes in HMEC-1 cells (Ades et al, 1992; 
Candal et al, 1996). Microvascular endothelial cells, as mentioned earlier, are resistant to the 
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cytolytic effect of TNF-α. However, TNF-α does induce a variety of other cell types to undergo 
apoptosis via extrinsic apoptosis pathways (Haimovitz-Friedman, 1997). While microvascular 
endothelial cells are resistant to the apoptogenic effect of TNF-α, the TNF-α-responsive genes 
such as IL-8, VEGF, E-selectin and VCAM-1 are upregulated by its presence in the HMEC-1 
endothelial cell line (Xu et al., 1994; Ades et al., 1992). 
We assayed B. henselae-infected HMEC-1 cells for endotoxin concentration using a 
standard limulus amoebacyte lysate (LAL) assay (FDA Guidelines, 1987). B. henselae endotoxin 
(212±4 EU/mL) was not effective at inducing cell death alone following 12 hour incubation, a 
time period that resulted in significant cell death in cultures containing an analogous quantity of 
purified E. coli LPS (data not shown). Based on previous comparative studies correlating 
bacterial colony forming units (c.f.u.) and endotoxin units (E.U.), this quantity of endotoxin 
would correspond to approximately 1x106 cfu/mL (Huntington et al., 2007). 
Other researchers have noted that apoptosis induced by bacterial LPS is potentiated by the 
addition of exogenous TNF-α or a protein synthesis inhibitor (Hull et al., 2002). During natural 
Gram-negative infection, the presence of bacterial Gram-negative LPS is an important factor for 
inducing host cell sphingolipid conversion (Franchi et al., 2006). Sphingolipid conversion leads 
to the generation of ceramide at the cell membrane. The use of ceramide as an apoptogenic agent 
is discussed in detail later. 
Bartonella henselae Infection and Death Receptors 
Our early experiments revealed a rapid downregulation of Fas-associated death domain 
(FADD) protein in HMEC-1 cells during the course of B. henselae infection (Figure 7). This 
downregulation of FADD protein expression indicates that either Fas or TNF-receptor-1 (TNF-
R1) pathway is affected by the presence of B. henselae.  
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Our initial observation of B. henselae-induced FADD protein downregulation was made 
in the absence of any additional exogenous apoptosis inducer. It was this early revelation that led 
to two important developments in our experimental design: 1) determination of B. henselae’s 
ability to circumvent apoptogenic actions on the part of the cell following a direct challenge with 
an apoptotic agent and 2) molecular characterization of pathways that utilize FADD as an 
integral apoptotic modulator (TNF-R1 and Fas-receptor dependent pathways). We therefore 
sought to determine if B. henselae were capable of “protecting” infected cells from apoptotic 
challenge. To this end we examined a cadre of apoptogenic agents and conditions with divergent 
modes of action (Table 2). Among these were exogenous TNF-α (Wesche-Soldato, et al. 2007; 
Guoqing and Goeddel, 2002), C2-ceramide (Smith and Schuchman, 2008), Staurosporine (Zhang 
et al., 2004), Camptothecin (Rath et al., 2008), etoposide/ET-18 (Torrecillas et al., 2006), Ricin 
toxin (Korcheva et al., 2007; Rao et al., 2005), Abrin toxin (Qu and Qing, 2004) and Serum 
starvation (Ajeno, et. al, 2004). Our examination of apoptosis inducing agents determined that 
C2-ceramide was most desirable for our experimental model (Zhang et al., 2002) for the 
following reasons: 1) camptothecin and etoposide yielded obliterated cell monolayers even at low 
concentrations, 2) staurosporine had the inverse effect, causing endothelial cell death only at 
higher concentrations but requiring a much longer time to exert its effect, and 3) ricin and abrin 
toxin effectively killed endothelial cells with no morphological evidence of apoptosis.  
True serum starvation is difficult to demonstrate with HMEC-1 cells and maintain 
microvascular endothelial characteristics (Xu et al., 1994; Velma George personal 
communication). The normal culture media contains 15% serum and historical information 
demonstrates that HMEC-1 cells undergo substantial loss of viability with as little as 5% serum. 
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C2-ceramide was the only apoptosis agonist we examined that provided a clear concentration-
dependent cytotoxic effect (Figure 2; Table 1), so it was the agent of choice for our experiments.  
C2-ceramide is a short-chained, cell permeable exogenous apoptosis inducer that is 
optimal for use with microvascular endothelial cell cultures (Fillet et al., 2003). First, exogenous 
ceramide treatment mimics the normal cellular responses to the presence of Gram-negative LPS 
exposure (Barber et al., 1996). Second, ceramide conversion plays an integral role in extrinsic 
pathway signaling. Lastly, of the apoptogenic agents tested, C2-ceramide demonstrates a linear 
dose and time dependence (Samadi, 2007; Figure 8).  
Sphingolipids and Their Role in Death Receptor Apoptosis Induction 
Metabolism of cell membrane sphingolipids generates endogenous ceramide in response 
to early apoptosis signaling events (Kolesnick, 2002; Ogretum and Hannun, 2004). A cellular 
function of ceramide is to modulate protein kinase pathways, leading to activation of downstream 
cellular apoptosis modulators (Basu et al., 1998). Another function of ceramide is in aiding in the 
formation of lipid rafts (Gulbins et al., 2004; Browne and London, 1998). Lipid raft formation 
facilitates the clustering of cell surface transmembrane receptors, including death receptors 
(Gulbins, 2003).  Clustered death receptors, specifically TNF-receptor-1 or Fas, are the initial 
signal for extrinsic apoptosis pathways (Gulbins and Li, 2006). 
Effect of B. henselae on Ceramide-induced Changes in Cellular Morphology  
Ceramide has a progressive effect on microvascular endothelial cell integrity, as 
demonstrated by gross cellular morphology for both ceramide-treated uninfected cells (Cer) and 
ceramide-treated B. henselae-infected cells (B+C). Both control uninfected (Figure 9A) and 
control B. henselae-infected cells consist of confluent cell monolayers (Figure 9B). Control cell 
morphology represents the end of the experimental timeline. The presence of some rounded cells 
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in the B. henselae alone control may be attributed to overconfluence of the endothelial cell 
monolayer. The obvious toxic effect of ceramide is more pronounced for Cer cells following 
longer ceramide treatment duration (Figure 9C, Figures 11A and C, Figures 12A and C). The 
appearance of Cer cells stands in stark contrast to their B. henselae-infected counterparts (B+C) 
withstanding the same ceramide challenge (Figure 9D, Figures 11B and D, Figures 12B and D).  
The progression of cellular damage emphasizes that ceramide is time-dependent in its cytotoxic 
morphological manifestation for microvascular endothelial cells.  
Previous research suggests that the presence of B. henselae allows the host cells to 
circumvent apoptosis progression (Kirby and Nekorchuk, 2002.; Minnick et al., 2003). It is 
important to note that the efficiency of B. henselae infection of cultured cells is approximately 
40% (Dr. Russell Regnery, personal communication). Our experience using Gimenez staining of 
B. henselae-infected HMEC-1 cells is in agreement with that estimate. In our model, the 
proximity of B. henselae to uninfected cells within the infected cellular monolayer did not 
alleviate cell death.  Therefore, we postulate that some loss of viability for B+C cells is due to 
uninfected cells within the B+C culture monolayer succumbing to the apoptogenic effect of 
ceramide. We observed no overriding “bystander” protective effect for uninfected cells from 
proximal B. henselae-infected cells. 
Trypan Blue was used to determine the cellular viability for both B. henselae-infected 
(B+C) and uninfected ceramide-treated cells (Cer) and control cells (Bird and Forrester, 1981). 
Trypan Blue determines viability due to exclusion of dye by the intact cellular outer membrane 
(Huggett and Suffolk, 1936). Assays that measure substrates of cellular respiration, such as those 
that use the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT), are desirable in some experimental models because their effects can be quantified. The 
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addition of bacteria (Gebran et al., 1994) and high serum concentrations in the cellular assay 
pose obstacles regarding the reliability of MTT assay results, however (MTT Assay Technical 
Data Sheet, Promega, Madison, WI). As mentioned previously, HMEC-1 cells do not maintain 
their desired cell characteristics when subjected to low serum concentrations (Ades et al., 1992). 
In addition, the presence of bacterial NAD dehydrogenase in the endothelial cell model creates 
aberrant results using MTT. For these reasons, we employed the use of Trypan Blue as a more 
reliable means of assessing viability considering the experimental parameters we used. In short, 
while both B+C and Cer cells experienced loss of viability, B. henselae-infected cells were 
markedly more viable and the endothelial cells were resistant to the cytotoxic effect of ceramide. 
Viability of ceramide treated uninfected cells rapidly declines in the time interval between 30 
minutes and 6 hours of treatment (Figure 13). While the presence of B. henselae in infected 
culture cells enhances overall cellular viability, there appears to be a level of cellular stress for 
the B+C cell culture as demonstrated by gross morphology when compared to uninfected- and 
untreated control cells. It is possible that the presence of B. henselae creates a competition for 
carbon sources in the cell culture media or more likely a mild shift in the media pH. Other 
researchers have demonstrated that prolonged exposure of endothelial cells to B. henselae 
promotes dramatic cell proliferation (Maeno et al., 1999; Dehio, 2003). Our research 
demonstrates that while B. henselae protects microvascular endothelial cells from apoptosis, it 
has little effect on cell proliferation within the experimental timeframe used here (data not 
shown). We assert that B. henselae’s intracellular survival tactic does not rely on enhancing cell 
proliferation and overall viability alone. Full characterization of the endothelial cell genes 
modulated during B. henselae intracellular infection would help to address this issue.  
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TRADD and FADD Intracellular Protein Expression 
 Contrary to the induction of gene expression, described in Chapter 3, changes in the 
intracellular protein concentration of TRADD and FADD can be caused by multiple factors. The 
percentage of TRADD/FADD positive cells indicates that these proteins are available from 
cytoplasmic pools, and could arise either from new transcription or translation, or from 
translocation from organelle storage. Untreated and uninfected cells have a consistent baseline of 
TRADD intracellular expression for both B+C and Cer cells (~13% positive cells). Following 
prolonged ceramide treatment, the percentage of TRADD positive cells increases for both B+C 
and Cer cells. Following the initiation of elevated TRADD expression, Cer cells maintain a high 
level of TRADD thereafter. Intracellular TRADD protein concentrations are likewise elevated for 
B+C cells, although the percentage of positive cells is nearly three-fold lower at its peak. 
An analysis of FADD concentrations reveals a pattern that is striking different from that 
of TRADD. The percentage of FADD positive Cer cells is elevated for all time-points. However, 
a comparison of B+C and Cer cells reveals two unique differences. First, the presence of B. 
henselae appreciably diminishes FADD levels at all time points. Second, the presence of B. 
henselae causes a suppression of FADD expression following prolonged ceramide treatment. In 
fact, the presence of B. henselae causes nearly a four-fold decrease in the percentage of FADD 
positive cells following 4 hours of ceramide treatment. 
Unlike TRADD, the cellular pool of FADD is not known (Screaton et al., 2003). FADD 
does possess a nuclear localization sequence. However, it has been demonstrated that in a single 
population FADD can be localized in either the cytoplasm or the nucleus (Gomez-Angelats and 
Cidlowski, 2003). TRADD is primarily stored in the endoplasmic reticulum. However, both 
nuclear import and export sequences for TRADD have been identified (Morgan et al., 2002; 
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Farrando-May, 2005). The permeabilization technique used in our studies is not sufficient to 
efficiently solubilize nuclear or endoplasmic reticulum membranes. Therefore, we conclude that 
the increase in TRADD levels is due to either new transcription, or translocation from the ER.  
Caspase Activity 
Caspase activity was assessed by the ability of available caspase to proteolytically cleave 
target peptides. The designer target peptides, which utilize a Europium-labeled reporter and a 
QSY-7 quencher, are “specific” for a particular caspase. The target peptide includes a target 
sequence that the enzymatically active caspase will cleave. The close proximity of the reporter 
and quencher in the intact target peptide results in total quenching of emitted signal following 
exposure to excitation. Proteolytic cleavage of the target peptide results in emission of a 
“fluorescent” signal following excitation. The LANCE system uses a caged chelated lanthanide 
(Europium) as the reporter molecule.  
The caspase-3 assay demonstrated that proteolytic activity was enhanced at all time points 
in Cer cells as compared to B+C cells. Additionally, caspase-3 activity was significantly 
enhanced for time points 1 to 4 hours over untreated control cells and untreated B. henselae 
infected cells. Caspase-3 enzymatic activity waned by 8 hours post ceramide treatment. As 
described previously, viability for both Cer and B+C cells is adversely affected by 8 hours 
ceramide treatment. This may account for the decline in caspase-3 activity. Additionally, all of 
the cellular substrates targeted by caspase-3 may be cleaved at this point, leading to a suppressive 
effect of caspase-3.  
In contrast to the results observed with caspase-3, caspase-6 proteolytic activity was 
enhanced in ceramide treated B. henselae-infected cells as compared to their uninfected 
counterparts. This result is in direct conflict with previous reports of B. henselae’s ability to 
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disrupt apoptosis (Kirby et al., 2001). Still, at no time point was the proteolytic activity 
significantly greater than that of untreated uninfected control cells, or untreated B. henselae-
infected control cells. The work of Kirby and Nekorchuk demonstrated that the presence of B. 
henselae suppressed caspase-3, caspase-8 and pan-caspase activity for control cells and serum-
starvation induced cell death. Their research utilized umbilical vein endothelial cells which have 
different responses to apoptosis stimuli than microvascular endothelial cells. In addition, our 
results demonstrate that the mere presence of B. henselae does not suppress enzymatic activity of 
caspase-3 and caspase-8. In fact for both caspase-3 and -8, B. henselae infected untreated cells 
have equal to or higher caspase activity for the respective caspase. The difference could simply 
be the use of two different cell models. The dynamics of apoptotic response tends to be tissue 
and cell specific. 
Like caspase-6, caspase-8 exhibited significantly enhanced activity in ceramide treated B. 
henselae-infected cells (B+C) relative to their uninfected counterparts, especially at the 3 and 4 
hour time-points. Moreover, untreated and uninfected control cells and untreated B. henselae-
infected control cells exhibited greater caspase-8 activity than either B+C or Cer cells. As 
mentioned previously, enzymatic activity of caspase proteins has been used as the empirical 
measure of caspase involvement. Caspase activation and caspase activity are not always 
synonymous (Kottke et al., 2001). We know that several caspase proteins do not need to be 
proteolytically active in order to carry out their function (Zimmerman and Green, 2001).  
The enzymatic activity counts of caspase-3 were at least three times those of either 
caspase-6 or -8. This is probably because caspase-3 is both the most abundant caspase and the 
initiator of both intrinsic and extrinsic apoptotic pathways. 
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Suppression of Overall Caspase Induction by B. henselae 
The MulticaspaseTM fluorescent assay is a broad spectrum caspase substrate that targets 
caspases-1, -3, -6, -7, -8 and -9. Again, this assay uses cleavage of fluorescent pan caspase target 
peptide to assess overall caspase activity. As a pan-caspase assay, it does not differentiate 
between the activites of individual caspases. B. henselae-infected cells treated with ceramide 
(B+C) exhibited a rapid, but truncated induction of overall caspases activity. The multicaspase 
assay revealed less overall caspase enzymatic activity in B + C cells than for cells treated with 
ceramide alone. More importantly, enhanced overall caspase activity for Cer cells lasted for a 
longer time (up to 6 hours). From these results, we conclude that the presence of B. henselae 
inhibits overall caspase induction caused by the induction of apoptosis.  
The work performed by Kirby and Nekorchuk did utilize a pan-caspase assay. In their 
research the presence of B. henselae suppressed pan-caspase activity. However their research 
employed a “pan-caspase” assay that is preferential for caspase-3 and -7 utilizing umbilical vein 
endothelial cells in the presence and absence of serum. Our data suggests that the presence of B. 
henselae suppresses pan-caspase activity (caspase-1, -3, -4, -5, -6, -7, -8 and -9) following 
ceramide-induced apoptsis using microvascular endothelial cell line.  
B. henselae Suppresses Ceramide-induced DNA Fragmentation  
Flow cytometric assessment of the DNA cell cycle utilizes propidium iodide (PI) as a 
DNA fluorescent intercalating dye to determine DNA content. Following cellular membrane 
permeabilization, PI intercalates into the DNA of any double-stranded DNA it encounters. 
Intercalated PI is stoichiometrically proportional to DNA content. The height of the fluorescent 
pulse is proportional to the intensity of the fluorescent signal, while the width of the signal is 
proportional to the time required for the permeabilized fluorescent cell to travel across the beam 
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of the laser. The area is calculated from the fluorescence integral to the cell that traveled across 
the laser. Fluorescence area is important if we were interested in discriminating DNA content of 
a cell doublet from the DNA content of a G2/M cell (Nunez, 2001).  
Considering the size of endothelial cells, the fluorescent height of a G0 singlet is the same 
as that of a G0 doublet because only one nucleus will occupy the laser space at a time. However, 
the width of a G0 doublet will be twice that of a G0 singlet because it will take twice as long to 
traverse the laser beam. Likewise, the fluorescent area of a G0 doublet will be twice that of a G0 
singlet (Zibigniew Darzynkiewicz, personal communication). The data were acquired by gating 
on the population that correspond to G0/G1/S/G2M singlet cells, excluding doublets, triplets and 
so on. Normal cell cycle distribution includes a large G1/G0 peak followed by a plateau of S-
phase cells and concludes with a G2/M peak of nearly ½ the height of the G1/G0 peak. Any peaks 
to the left of or smaller than the G1/G0 peak are considered to be sub-G1/G0 peaks and therefore 
apoptotic.  
We chose to display DNA content using FL-2 height because it allows us to display in a 
log scale, making all low molecular weight DNA visible. Most low molecular weight DNA is 
precluded from view when assessed in a linear FL-2 area histogram. However, a large sub-G1/G0 
population is observed at six hours of ceramide treatment for the Cer cells (Figure 23H). Eight 
hours of ceramide treatment produces a complete loss of DNA cell cycle integrity for Cer cells, 
as determined by a flattening of peak height (Figure 28J). In contrast, the B + C cells show no 
significant apoptotic population up through six hours of ceramide treatment (Figure 23G). Only 
after eight hours of ceramide treatment does a small apoptotic peak begin to emerge. 
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CHAPTER 3 
BARTONELLA INHIBITS GENE EXPRESSION OF APOPTOSIS MODULATORS 
 
Introduction 
Intracellular pathogens are known to influence gene expression in their host cells (Darby 
et al., 2007). Genes whose expression is increased by these pathogens include proliferation 
associated genes, anti-apoptosis associated genes and in some cases apoptosis genes (Gao and 
Kwaik, 2000). It is well known that bacteria, in particular Bartonella species, influence the 
expression of NF-κB associated gene products (Dehio, 2001). B. henselae exploits all of the 
extrinsic genes within the TNF-R1 pathway. This is intriguing due to the fact that endothelial 
cells, the usual host for this bacterium, are not responsive to the apoptosis effects of TNF-α 
(Viemann et al., 2006).  
To ensure chronic intracellular infection, B. henselae must inhibit apoptosis. As 
previously described, B. henselae suppresses the protein expression and activity of several TNF-
R1 dependent pathway modulators. The experiments described here were designed to determine 
the effect of B. henselae infection on gene expression following direct apoptotic challenge. Two 
commonly used methods designed to investigate changes in gene expression are microarray 
analysis and approaches involving real-time RT-PCR. The use of ceramide, our selected 
apoptogenic agent, precluded the use of expression microarray chips due to the fact that the 
cytotoxity of ceramide dramatically reduced the number of intact cells and thereby the total 
mRNA concentration (Nagata et al., 2003). Therefore, we chose to investigate the effect of B. 
henselae on gene expression using multiplex real-time PCR. 
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Real-time RT-PCR assays measure the amount of transcript that is present in a given 
sample under a defined set of conditions.  Following reverse transcription of the targeted RNA, 
.the amount of gene product is monitored after each amplification cycle and the number of cycles 
required for the product concentration to reach a pre-defined threshold (CT) is determined. The 
higher the CT value (i.e., the longer it takes to reach the designated threshold concentration), the 
lower the initial concentration of the RNA in the original sample Thus, the CT value provides an 
estimate of the “quantity” for the specific gene target. By comparing the CT value for a gene-of-
interest (GOI) to the CT value of a benchmark or normalizing gene such as glyceraldehyde-6-
phosphate dehydrogenase (GAPDH), the relative abundance of that GOI can be determined. 
Approximately 3.3 cycles change in the CT value is equal to one log, or a 10-fold difference in 
gene expression. Multiplexing the real-time RT-PCR assay provides an added advantage, since it 
allows for simultaneous comparisons within a single reaction vessel. 
 
Materials and Methods 
RNA Extraction  
Suspended and floating cells were pelleted from the media of 6-well culture dishes and 
spun for 3 minutes at 1,000 xg. Cell monolayers and pelleted cells were pooled together. Cells 
were lysed with 100 μL of Roche MagNApure RNA II Lysis Buffer (Roche, Indianapolis, IN.). 
RNA II Lysis Buffer, at a volume of 100 μL, was added to the sample processing tray for each 
sample. The total volume of lysed cells in the RNA II Lysis Buffer was added to the sample 
processing tray according to the manufacturers’ protocol. RNA extraction was performed using 
the robotic MagNApure system using the RNA II kit following the High Performance RNA II 
protocol according to manufacturers’ instructions.  
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RNA was pelleted by adding 100 μL 95% ethanol, then decanting off the ethanol. 
Contaminating DNA was removed by adding 5 μL RNase-Free DNase I and bringing the total 
volume up to 200 μL with 1X DNase Buffer (Epicentre, Madison, WI). The dissolved RNA was 
incubated for 30 minutes at 37 oC. A volume of 200 μL of 2x T and C Lysis Solution was added 
followed by vortexing for 5 seconds. A volume of 200 μL of MPC Protein was added and the 
solution was vortexed for 10 seconds and placed on ice for 5 minutes. Debris was pelleted by 
centrifugation at 10,000 xg in a microcentrifuge. The supernatant was transferred to an RNase-
free microfuge tube, after which 500 μL of isopropanol was added and the tube inverted several 
times.  
The purified RNA was pelleted by centrifugation at 4 oC for 10 minutes. The RNA pellet 
was washed 2x with 75% ethanol, in nuclease-free water, and centrifuged at 10,000 xg for 5 
minutes. RNA pellet was dissolved in 200 μL TE buffer supplemented with tRNA added to a 
final concentration of 1 μg/100 μL (Ambion, Austin, TX). tRNA was also added to nuclease-free 
water (Promega, Madison, WI) at 10 μg/mL, for all RNA dilutions.  
Real-time RT-PCR Primers 
Primer sequences were as follows.  
Glyceraldehyde-3-phosphate dehydrogenase  
(GAPDH) forward 5’-TGGGCTACACTGAGCACCAG-3’ 
Glyceraldehyde-3-phosphate dehydrogenase  
(GAPDH) reverse 5’-CAGCGTCAAAGGTGGAGGAG-3’ 
Caspase-8 (Cas8) forward 5’-GCCTGGACTACATTCCGCA-3’ 
Caspase-8 (Cas8) reverse 5’-CCTGGAGTCTCTGGAATAACATCA-3’ 
Caspase-3 (Cas3) forward 5’-TGTTCCATGAAGGCAGAGCC-3’ 
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Caspase-3 (Cas3) reverse 5’-TGCGTATGGAGAAATGGGC-3’ 
FADD forward 5’-CTTCGGATGAGGCCCTCAT-3’ 
FADD reverse 5’-TCTAGGGCACTGCAGGGCT-3’ 
TRADD forward 5’-GATGGCAGCTGGGCAAAAT-3’ 
TRADD reverse 5’-GCGAGGACTCCACAAACAGG-3’. 
Probes 
Target probe sequences and chemistries are as follows.  
GAPDH probe 5’FAM-TGGTCTCCTCTGACTTCAACAGCGACAC-3’BHQ;  
Cas8 probe 5’YamY-AGGAAGCAAGAACCCATCAAGGATGCC-3’BHQ;  
Cas3 probe 5’Cy5-TGGACCACGCAGGAAGGGCC-3’BHQ;  
FADD probe 5’-YakY-CCCATTCGGGAGATCATGTCTCACTTCA-BHQ-3’ 
TRADD probe 5’-Cy5-CACGAAGAGTGGGTGGGCAGCG-BHQ-3’;  
Multiplex RT-PCR Conditions  
Multiplex RT-PCR Master Mix contained the following components per reaction: 11.5 
μL QuantitectTM Probe RT-Master Mix, 0.25 μL QuantitectTM RT Mix (Qiagen, Valencia, CA); 
2.5 μL LC-FastStart Enzyme w/o MgCl2 (Roche, Indianapolis, IN) and 0.125 μL nuclease-free 
water (Promega, Madison, WI). The multiplex RT-PCR Master Mix components were 
supplemented with an additional 0.5 mM MgCl2 (Roche, Indianapolis, IN), 0.8 mM dNTPs 
(Promega, Madison, WI) and 5 U per reaction Platinum TaqTM (Invitrogen, Carlsbad, CA). 
The Qiagen RT Mix contains a proprietary mixture of OmniscriptTM and SensiscriptTM 
reverse transcriptases, and HotstartTM Taq DNA polymerase and 4mM MgCl2.  Further, the 
QuantitectTM Probe RT-PCR Master Mix contains a proprietary mixture of dNTPs and buffers. 
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Primers/probes were used at the following concentrations: GAPDH primers/probe at 
250nM/50nM; and FADD and TRADD primers/probe at 500nM/100nM and 1000 nM/200nM 
respectively. GAPDH, Cas8 and Cas3 primers/probe were used at 250nM/50nM, 500/100 nM 
and 1000nM/200nM, respectively. Cycling conditions were 48 oC for 30 minutes, 95 oC for 15 
minutes followed by 45 cycles of 95 oC for 10 seconds and 60 oC for 90 seconds. Data were 
acquired (i.e., optics were on) during the 60 oC step. 
 
Results 
Real-time RT-PCR was used to determine the effect of B. henselae infection on the 
expression of selected apoptosis-associated genes. As an initial step, parameters optimizing the 
conditions for reproducible amplification were established. Development of real-time PCR assay 
conditions involves the selection of an optimal primer/probe set, the titration of primer/probe 
combinations to determine optimal concentration, the titration of the optimal MgCl2 
concentration, and determination of the need for supplemental components to ensure RNA 
template integrity. Several genetic targets were evaluated for assessing apoptosis induction 
(Table 2).  
The panel of primer/probe sets described in Table 2 was designed using Primer 
ExpressTM software. Complete mRNA sequences of the desired human apoptotic genes were 
analyzed by BLAST gene sequences available through GenBank. Targets that had multiple 
primer/probe options were further screened to determine the optimal primer/probe set (Figure 
24). Different primer/probe sets directed against the same gene target can display variability in 
the efficiency of amplification and signal intensity for that gene target. For this reason each 
possible gene target primer/probe set is screened for amplification efficiency. For the sake of 
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simplicity, screening of primer probe sets is paired with MgCl2 titration (Figure 24). The addition 
of supplemental yeast tRNA was determined at the onset to be necessary to ensure RNA stability 
and reproducible curves (Figure 25). tRNA was added to all RNA stocks and template diluent to 
both stabilize the target and ensure proper template recovery from frozen template.  
Optimal primer/probe concentrations were determined by serial two-fold titration of 
primer/probes from 1μM/200nM to 250nM/50nM (Figure 26). The primer/probe set for a desired 
gene target that demonstrated: 1) a strong reproducible fluorescent signal, and 2) the absence of a 
no-template-controls (NTC) signal, was selected for further study (See Materials and Methods 
primer and probe sequences). Previous experience demonstrated that additional dNTP’s and 
supplemental Platinum TaqTM were necessary for multiplexing a real-time PCR assay (data not 
shown). 
Standard curves of RNA template verify both the efficacy and robustness for real-time 
RT-PCR assays under the conditions optimized above. A linear dilution series demonstrates that 
each real-time RT-PCR assay is reliable across a wide concentration range. The linearity of the 
CT curve provides verification that amplification efficiency is maintained across a linear dilution 
series of input template for TRADD (Figure 27), FADD (Figure 28), Caspase-8 (Figure 29) and 
Caspase-3 (Figure 30). In addition to standard curves for each gene target using control cells,  
RNA templates were isolated from infected and uninfected cell samples after 1, 2, 3, 6 and 12 
hours of ceramide treatment. The efficiencies of gene amplification ranged between 90% and 
100% for all gene targets, all sample types and all time points (data not shown).  
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Table 2. Gene Targets Tested.  
Target Number of primer/probe sets 
tested 
Fluorophore 
18S rRNA 1 FAM 
RNAse P 1 FAM 
β-actin 1 FAM 
GAPDH 2 FAM 
TRADD 3 Cy5 
FADD 2 Yak Yellow 
Fas 2 Yak Yellow 
Caspase-8 3 Yak Yellow 
Caspase-3 2 Cy5 
MDR-1 1 Yak Yellow 
TGF-β 1 Yak Yellow 
Several targets were selected for assessing apoptosis induction. The number of primer/probe sets 
was determined by Primer Express software blast of target gene sequences. Targets that had 
multiple primer/probe sequences were further screened to determine the optimal primer/probe 
set. Fluorophore listed is the dye used for the optimal primer/probe set. 
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Figure 24. Supplemental Magnesium Titration and Multiple RT-PCR Primer/Probe Sets. 
Each gene target primer probe set was optimized for supplemental magnesium in PCR Master 
Mix.  The cluster of markers cross the threshold between cycle 26-28. Prospective primer probe 
sets were identified by Primer ExpressTM software (Roche, Indianapolis, IN.) 
 
 
 
Figure 25. Reproducibility of Multiplex RT-PCR Requires tRNA. Real-time RT-PCR does 
not yield reproducible CT values in the absence of stabilizing tRNA. Replicates of a single RNA 
template aliquot demonstrate a wide range of cycle-threshold (CT ) values  
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Figure 26. Primer and Probe Titration. A linear dilution of primer/probe were used to 
determine optimal primer/probe concentration. Optimal primer/probe concentrations were 
determined for each gene target (FADD primer/probe used as example). 
 
Most test samples were >95% efficient for amplification. RNA templates from infected cells 
exhibited little variability in CT values across all time points, as compared to a slightly broader 
variability in CT values for cells treated with ceramide alone across all time points (data not 
shown).  
Use of Multiplex Real-Time RT-PCR to Measure Relative Apoptotic Gene Expression for 
Early and Late Apoptotic Genes  
Multiplex real-time RT-PCR provides a graphic and simultaneous representation of the gene 
expression for the gene-of-interest (GOI) and the reference house-keeping gene. 
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Figure 27. Standard Curve of TRADD Gene Expression. A comparison of standard curves for 
TRADD gene expression. RNA templates from control cells were diluted in a serial fashion. The 
curves demonstrate linear gene expression of TRADD as a function of serial dilution of gene 
template. Successive 2-fold dilutions of template yield corresponding increases in CT values.  
 
y = -3.582 + 22.509 
Slope= -3.5874 
R2 =0.9947 
E = 1.9000 
y= -3.6682 + 30.604 
Slope = -3.3219 
R2 = 0.9953 
E = 2.0000 
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Figure 28. Standard Curve of FADD Gene Expression. A comparison of standard curves for 
FADD gene expression. RNA templates from control cells were diluted in a serial fashion. The 
curves demonstrate linear gene expression of FADD as a function of serial dilution of gene 
template. Successive 2-fold dilutions of template yield corresponding increases in CT values.  
 
y = -3.6159 + 29.46 
Slope = -3.3219 
R2 =0.9953 
E = 2.0000 
 
y = -3.582 + 22.509 
Slope = -3.5874 
R2 =0.9953 
E = 1.900 
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Figure 29. Standard Curve of Caspase-8 Gene Expression. A comparison of standard curves 
for Caspase-8 gene expression. RNA templates from control cells were diluted in a serial fashion. 
The curves demonstrate linear gene expression of Caspase-8 as a function of serial dilution of 
gene template. Successive 2-fold dilutions of template yield corresponding increases in CT 
values.  
y = -3.9161 + 31.217 
Slope = -3.3219 
R2 =0.9953 
E = 2.000 
 
   
y = -3.582 + 22.509 
Slope = -3.5874 
R2 =0.9953 
E = 1.900 
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Figure 30. Standard Curve of Caspase-3 Gene Expression. A comparison of standard curves 
for Caspase-3 gene expression. RNA templates from control cells were diluted in a serial fashion. 
The curves demonstrate linear gene expression of Caspase-3 as a function of serial dilution of 
gene template. Successive 2-fold dilutions of template yield corresponding increases in CT 
values.  
 
y = -3.6791x + 28.04 
Slope = -3.3219 
R2 =0.9953 
E = 2.000 
 
   
y = -3.582 + 22.509 
Slope = -3.5874 
R2 =0.9953 
E = 1.900 
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In the analysis conducted here, the gene-of-interest (TRADD, FADD, Caspase-8, or Caspase-3) 
is normalized to the reference housekeeping gene (GADPH) for each sample by subtracting the 
average CT value of the reference gene (GAPDH) from the average CT value for the GOI, called 
∆CT. The normalized GOI from the sample of interest or focus sample, is then subtracted from 
the normalized GOI of the standardizing sample (Winer et al., 1999; Livak and Schmittgen, 
2001). The normalized gene expression of the reference sample is subtracted from the 
normalized gene expression of the test sample which is called the ΔΔCT. Specifically, relative 
gene expression (R.E.) is mathematically determined as follows: 
R.E.= 2^(Normalized Gene Expression Test Sample)-(Normalized Gene Expression Reference Sample) 
R.E=2^(GOI Test-NG Test)-( GOI Reference-NG Reference) 
Ref. Sample= cell template used as “benchmark” reference or calibrator sample 
Test Sample= sample where the gene expression level is desired. 
GOI=gene of interest (target gene) 
NG=Normalizing gene (GAPDH) or glyceraldehyde-6-phosphate dehydrogenase. 
It is worth noting that by adjusting which sample is the test and which is the reference or 
calibrator one can determine the gene expression fold-increase as it relates to the reference 
sample. 
Apoptosis was induced by ceramide treatment of uninfected and B. henselae-infected 
cells, and its effect on gene expression was monitored in a time-dependent manner. Gene 
expression was determined for the gene targets TRADD, FADD, caspase-8 and caspase-3 and the 
normalizing house-keeping gene, GAPDH, as described. Enhanced gene expression was defined 
as the net difference in transcript production for the uninfected cells and infected cell (Figures 27, 
28, 29 and 30). 
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TRADD Gene Expression  
Real-time RT-PCR revealed a time-dependent trend in enhanced TRADD gene 
expression for ceramide-treated cells. After a single hour of treatment, there was virtually no 
separation in TRADD CT curves for RNA isolated from neither infected or uninfected cells, nor 
was there detectable separation of the GAPDH CT curves (Figure 31A). After 2 hours, however, 
there was a significant increase in the separation in the GAPDH curves (Figure 31B, ~4.15 
cycles) for Cer cells as compared to B+C cells with an average fold increase of 13.14 (Figure 32) 
and a ΔΔCT of -3.72 (Table 3). Likewise at the same time-point the fold increase was 9.76 and 
0.51 for Cer cells vs Controls and B+C cells vs. Controls, respectively (Figure 32; Table 2B and 
2C).  By 3 hour of ceramide treatment the fold-increase in TRADD gene expression was 3.91, 
2.00 and 0.74 for Cer vs B+C, Cer vs Control and B+C vs Control, respectively (Figure 32; Table 
3).  
FADD Gene Expression  
Real-time RT-PCR analysis reveals an enhancement of FADD expression similar to 
that which was observed with the TRADD gene. Following one hour of ceramide treatment, no 
separation of FADD CT curves for templates derived from either infected or uninfected cells 
was detected (Figure 33A), but after two hours, there was a significantly higher level of the 
FADD transcript (relative to the GADPH standard) in the ceramide treated uninfected cells.  
The difference became even more pronounced after three hours (Figure 33B), with a 4.84 and 
2.43 fold increase for Cer vs B+C and Cer vs Control, respectively (Figure 34; Table 4A and 
4C). FADD gene expression returned to baseline by the 6-hour time point. 
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Figure 31. Multiplex Real-time RT-PCR for TRADD Gene Expression. TRADD gene 
expression (upper panel) is normalized to GAPDH gene expression (lower panel). Gene 
expression of TRADD is shown at 1 hour (Figure 31A) and 2 hour (Figure 31B). Ceramide 
treatment for 1 hour had no significant variation in gene expression between sample types. Two 
hour ceramide treatment demonstrates enhanced gene expression for TRADD (Figure 31B). 
Figure 31 is representative of multiple independent experiments (n=3). Experimental samples 
were run in triplicate 
TRADD A 
B 
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Figure 32. TRADD Gene Expression. Gene expression is represented as relative fold-increase 
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer) 
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the 
ΔΔCT method. Values represent mean of fold-increase.  
 
Caspase-8 and Caspase-3 Gene Expression  
As with TRADD and FADD gene expression, the level of expression of the genes coding 
for Caspase-8 and Caspase-3 in B. henselae-infected cells following ceramide treatment was 
found to be significantly less than that of the uninfected control cells.  The differences in gene 
expression became apparent at two hours post-ceramide treatment, reaching a peak at two hours 
for caspase-8 (4.45 fold-increase, Figure 36; Table 5) and caspase-3 (3.68 fold-increase, Figure 
38; Table 6), then decreasing over the course of the next several hours (Figure 36 and 38; Table 5 
and 6). 
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Table 3. TRADD Gene Expression Summary.  
Cer vs 
B+C TRADD 1 hr 1.5 hr 2 hr 3 hr 6 hr 12 hr 
 A Fold-increase 1.56 5.34 13.14 3.91 0.74 1.09 
  STDEV 0.43 0.59 0.69 2.39 0.02 0.03 
  GOI (Test) 26.27 28.11 28.04 28.95 29.75 28.22 
  
Norm Gene 
(Test) 16.95 21.26 22.19 20.65 19.05 18.28 
  ΔCT 9.32 27.89 5.86 8.30 10.50 9.94 
  GOI (Ref) 26.43 26.93 27.56 27.50 27.96 27.20 
  
Norm Gene 
(Ref) 16.86 17.72 17.99 17.38 17.68 17.13 
  ΔCT 9.94 9.27 9.57 10.12 10.28 10.07 
  ΔΔCT -0.61 -2.41 -3.72 -1.82 0.43 -0.13 
B+C vs 
Ctrl TRADD 1 hr 1.5 hr 2hr 3 hr 6 hr 12 hr 
 B Fold-increase 0.52 0.45 0.51 0.74 0.92 0.75 
  STDEV 0.15 0.08 0.01 0.08 0.12 0.22 
  GOI (Test) 27.20 27.96 27.50 27.56 26.93 26.80 
  
Norm Gene 
(Test) 17.13 17.68 17.38 17.99 17.67 16.86 
  ΔCT 10.07 10.28 10.12 9.57 9.27 9.94 
  GOI (Ref) 26.66 26.66 26.77 26.77 26.77 26.05 
  
Norm Gene 
(Ref) 17.56 17.56 17.63 17.63 17.63 16.56 
  ΔCT 9.10 9.10 9.14 9.14 9.14 9.49 
  ΔΔCT 0.96 1.18 0.98 0.43 0.13 0.45 
Cer vs 
Ctrl TRADD 1 hr 1.5 hr 2 hr 3 hr 6 hr 12 hr 
 C Fold-increase 1.12 4.89 9.76 2.00 0.33 0.58 
  STDEV 0.03 0.09 0.57 1.26 0.07 0.18 
  GOI (Test) 26.27 28.11 28.04 28.95 29.75 28.22 
  
Norm Gene 
(Test) 16.95 21.75 22.19 20.65 19.05 18.28 
  ΔCT 9.32 6.85 5.86 8.30 10.71 9.94 
  GOI (Ref) 26.05 26.77 26.77 26.77 26.66 26.66 
  
Norm Gene 
(Ref) 16.56 17.63 17.63 17.63 17.56 17.56 
  ΔCT 9.49 9.14 9.14 9.14 9.10 9.10 
  ΔΔCT -0.16 -2.29 -3.29 -0.84 1.61 0.84 
 
TRADD gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B. 
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control cells 
and ceramide treated unifected cells (Cer) versus control cells
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Figure 33. Multiplex Real-time RT-PCR for FADD Gene Expression. FADD gene 
expression (upper window) is normalized to GAPDH gene expression (lower window). 
Following 1 hour ceramide treatment, there was no significant variation in gene expression 
between sample types (Figure 33A). Two hour ceramide treatment demonstrates enhanced 
gene expression for FADD (Figure 33B). Figure 33 is representative of multiple 
independent experiments (n=3). Experimental samples were run in triplicate.  
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Figure 34. FADD Gene Expression. Gene expression is represented as relative fold-increase 
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer) 
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the 
ΔΔCT method. Values represent the mean of the fold-increase. Enhanced expression levels 
were described is determined to be statistically significant (p<0.05). Gene expression is 
determined by multiple independent real-time RT-PCR experiments (n=3). Experimental 
samples were run in triplicate. 
 
Use of Non-treated Control Cells As Normalizing Samples In Apoptotic Gene Expression 
Profiles  
To generate a true baseline for gene expression in each of the experimental samples, we 
compared the fold-increase in apoptotic gene expression for uninfected and infected cells to the 
corresponding values for untreated uninfected and infected control cells (TRADD; Figure 39, 
FADD; Figure 40, Caspase-8; Figure 41 and Caspase-3; Figure 42). Following treatment of 
uninfected cells with ceramide, there was a significant increase in the expression of all four 
apoptotic genes tested relative to untreated control cells (Tables 3C, 4C, 5C and 6C) 
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Table 4. FADD Gene Expression Summary.  
Cer vs 
B+C FADD 1 hr 1.5 hr 2 hr 3 hr 6 hr 12 hr 
 A Fold-increase 1.63 3.87 3.98 4.84 0.89 0.98 
  STDEV 0.09 0.50 0.08 0.95 0.08 0.38 
  GOI (Test) 26.27 27.67 27.30 27.10 27.57 26.57 
  
Norm Gene 
(Test) 16.86 17.67 17.99 17.38 17.68 17.13 
  ΔCT 8.70 8.06 7.68 7.46 10.06 9.53 
  GOI (Ref) 25.65 29.32 29.87 28.11 29.10 27.81 
  
Norm Gene 
(Ref) 29.75 21.26 22.19 20.65 19.05 18.28 
  ΔCT 9.15 9.42 9.02 9.25 9.36 9.05 
  ΔΔCT -0.70 -1.81 -1.63 -2.26 0.17 0.09 
B+C vs 
Ctrl FADD 1 hr 1.5 hr 2 hr 3 hr 6 hr 12 hr 
 B Fold-increase 0.92 0.74 0.66 0.50 0.48 0.66 
  STDEV 0.12 0.08 0.01 0.03 0.00 0.11 
  GOI (Test) 26.27 27.67 27.30 27.10 27.57 26.57 
  
Norm Gene 
(Test) 16.86 17.67 17.99 17.38 17.68 17.13 
  ΔCT 9.41 10.01 9.31 9.72 9.89 9.44 
  GOI (Ref) 25.69 26.35 26.35 26.35 26.39 26.39 
  
Norm Gene 
(Ref) 16.56 17.63 17.63 17.63 17.56 17.56 
  ΔCT 9.13 8.72 8.72 8.72 8.83 8.83 
  ΔΔCT 0.28 1.29 0.59 1.01 1.06 0.60 
Cer vs 
Ctrl FADD 1 hr 1.5 hr 2 hr 3 hr 6 hr 12 hr 
 C Fold-increase 1.37 1.57 2.13 2.43 0.43 0.67 
  STDEV 0.39 0.03 0.80 0.62 0.04 0.36 
  GOI (Test) 25.65 29.32 29.87 28.11 29.10 27.81 
  
Norm Gene 
(Test) 16.95 21.26 22.19 20.65 19.05 18.28 
  ΔCT 8.70 8.06 7.68 7.46 10.06 9.53 
  GOI (Ref) 25.69 26.35 26.35 26.35 26.39 26.39 
  
Norm Gene 
(Ref) 16.56 17.63 17.63 17.63 17.56 17.56 
  ΔCT 9.13 8.72 8.72 8.72 8.83 8.83 
  ΔΔCT -0.43 -0.66 -1.04 -1.26 1.22 0.69 
 
FADD gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B. 
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control 
cells and ceramide treated unifected cells (Cer) versus control cells
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Figure 35. Multiplex Real-time RT-PCR for Caspase-8 Gene Expression. Caspase-8 
gene expression (A, upper window) is normalized to GAPDH gene expression (B, lower 
window). Following 1 hour ceramide treatment, there was no significant variation in gene 
expression between sample types (Figure 35A). Two hour ceramide treatment demonstrates 
enhanced gene expression for Caspase-8 (Figure 35B). Figure 35 is representative of 
multiple independent experiments (n=3). Experimental samples were run in triplicate.  
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Figure 36. Caspase-8 Gene Expression. Gene expression is represented as relative fold-increase 
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer) 
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the 
ΔΔCT method. Values represent mean of fold increase. Enhanced expression described is 
determined to be statistically significant (p<0.05). 
 
In contrast, ceramide treatment has little or no effect on the expression of these genes in cells that 
have been infected with B. henselae. These results strongly suggest that B. henselae infection 
interferes with the expression of apoptotic genes. 
 
Discussion 
Real-time RT-PCR Assay Development  
Microarray analysis and real-time RT-PCR both have the potential to generate large 
amounts of information about gene expression. In general, microarrays are considered to provide 
a more complete representation of cellular genome than real-time RT-PCR. However, the use of 
microarrays would have raised significant difficulties under the experimental parameters we 
employed. 
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Table 5. Caspase-8 Gene Expression Summary.  
 
Cer vs. B+C Caspase-8 1 hr 2 hr 3 hr 6 hr 12 hr 
 A Fold-increase 1.40 4.45 4.47 0.91 0.28 
  STDEV 0.14 1.31 0.57 0.17 0.13 
  GOI (Test) 26.02 26.65 27.06 26.90 29.24 
  
Norm Gene 
(Test) 17.36 17.97 17.99 18.01 18.77 
  ΔCT 8.18 6.56 6.92 9.05 10.47 
  GOI (Ref) 25.44 29.13 28.16 28.66 26.18 
  Norm Gene (Ref) 17.26 22.57 21.25 19.61 17.67 
  ΔCT 8.67 8.68 9.07 8.89 8.52 
  ΔΔCT -0.48 -2.11 -2.15 0.16 1.96 
B+C vs Ctrl Caspase-8 1 hr 2 hr 3 hr 6 hr 12 hr 
 B Fold-increase 1.59 1.53 1.07 1.08 1.86 
  STDEV 0.85 0.66 0.45 0.98 1.24 
  GOI (Test) 17.36 17.97 17.99 18.01 26.18 
  
Norm Gene 
(Test) 17.36 17.97 17.99 18.01 17.67 
  ΔCT 8.67 8.68 9.07 8.89 8.52 
  GOI (Ref) 25.30 25.30 25.56 25.56 25.68 
  Norm Gene (Ref) 16.09 16.09 16.47 16.95 16.47 
  ΔCT 9.21 9.21 9.09 8.61 9.21 
  ΔΔCT -0.54 -0.53 -0.03 0.28 -0.69 
Cer vs Ctrl Caspase-8 1 hr 2 hr 3 hr 6 hr 12 hr 
 C Fold-increase 2.30 6.67 4.93 0.95 0.44 
  STDEV 1.62 1.23 2.61 0.87 0.26 
  GOI (Test) 25.44 29.13 28.16 28.66 29.24 
  
Norm Gene 
(Test) 17.26 22.57 21.25 19.61 18.77 
  ΔCT 8.18 6.56 6.92 9.05 10.47 
  GOI (Ref) 25.30 25.30 25.56 25.56 25.68 
  Norm Gene (Ref) 16.09 16.09 16.47 16.95 16.47 
  ΔCT 9.21 9.21 9.09 8.61 9.21 
  ΔΔCT -1.02 -2.64 -2.18 0.44 1.26 
 
Caspase-8 gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B. 
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control 
cells and ceramide treated unifected cells (Cer) versus control cells. 
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Figure 37. Multiplex Real-time RT-PCR for Caspase-3 Gene Expression. Caspase-3 gene 
expression (A, upper window) is normalized to GAPDH gene expression (B, lower window). 
Following 1 hour ceramide treatment, there was no significant variation in gene expression 
between sample types. Two hour ceramide treatment demonstrate enhanced gene expression for 
caspase-3 (Figure 37B). Figure 37 is representative of multiple independent experiments (n=3). 
Experimental samples were run in triplicate.
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Figure 38. Caspase-3 Gene Expression. Gene expression is represented as relative fold-increase 
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer) 
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the 
ΔΔCT method. Values represent mean of fold increase. Enhanced expression described is 
determined to be statistically significant (p<0.05). Gene expression is determined by multiple 
independent real-time RT-PCR experiments (n=3). Experimental samples were run in triplicate. 
 
For instance, the amount of RNA template required for microarray analysis, derived from in vitro 
cell culture, would have been prohibitively large when considering multiple time points and other 
experimental conditions that we had to address. Moreover, the addition of C2-ceramide, resulting 
as it does in large-scale cell death of uninfected cells, would seriously affect the ability to isolate 
RNA samples at levels high enough to analyze. To overcome these hurdles, real-time RT-PCR 
was used as it requires substantially less RNA template. In addition to its ability to optimize 
experimental parameters in ways that minimize the quantity of input template, real-time RT-PCR 
can be conducted at significantly lower cost than microarray analysis. The robustness of a real-
time RT-PCR assay is dependent on the design of the primer/probe set. Primer/probe sets were 
designed using BLAST gene sequences available through GenBank.  
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Table 6. Caspase-3 Gene Expression Summary. 
Cer vs Ctrl Caspase-3 1 hr 2 hr 3 hr 6 hr 12 hr 
 A Fold-increase 1.71 3.75 2.65 1.45 1.10 
  STDEV 0.19 0.59 0.28 0.39 0.52 
  GOI (Test) 23.61 27.79 26.73 25.51 25.21 
  
Norm Gene 
(Test) 17.26 22.57 21.25 19.61 18.77 
  ΔCT 6.36 5.22 5.48 5.90 6.44 
  GOI (Ref) 23.21 23.21 23.35 23.35 22.92 
  Norm Gene (Ref) 16.09 16.09 16.47 16.95 16.47 
  ΔCT 7.12 7.12 6.88 6.40 6.45 
  ΔΔCT -0.76 -1.90 -1.40 -0.50 -0.01 
B+C vs Ctrl Caspase-3 1 hr 2 hr 3 hr 6 hr 12 hr 
 B Fold-increase 1.25 0.79 0.92 1.43 0.76 
  STDEV 0.61 0.39 0.32 0.86 0.47 
  GOI (Test) 23.78 25.07 25.03 24.46 24.10 
  
Norm Gene 
(Test) 17.26 22.57 21.25 19.61 18.77 
  ΔCT -2.25 -1.58 -2.03 -2.45 -2.08 
  GOI (Ref) 23.21 23.21 23.35 23.35 22.92 
  Norm Gene (Ref) 16.09 16.09 16.47 16.95 16.47 
  ΔCT -2.09 -2.09 -2.21 -2.21 -2.76 
  ΔΔCT -0.16 0.51 0.19 -0.23 0.68 
Cer vs. B+C Caspase-3 1 hr 2 hr 3 hr 6 hr 12 hr 
 C Fold-increase 1.05 3.68 2.95 1.47 1.02 
  STDEV 0.18 0.44 0.10 0.26 0.28 
  GOI (Test) 23.61 27.79 26.73 25.51 25.21 
  
Norm Gene 
(Test) 17.26 22.57 21.25 19.61 18.77 
  ΔCT 1.17 0.38 0.52 0.87 1.30 
  GOI (Ref) 23.78 25.07 25.03 24.46 24.10 
  Norm Gene (Ref) 17.36 17.97 17.99 18.01 17.67 
  ΔCT 6.42 7.10 7.04 6.44 6.43 
  ΔΔCT -0.06 -1.87 -1.56 -0.54 0.01 
 
Caspase-3 gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B. 
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control 
cells and ceramide treated unifected cells (Cer) versus control cells. 
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Figure 39. Multiplex Real-time RT-PCR for TRADD Controls. TRADD gene expression 
(upper window) as compared to GAPDH gene expression (lower window). RNA templates 
corresponding to 1, 4 and 12 hour ceramide-treatment time-points. TRADD gene expression 
demonstrates little variability in uninfected and non-apoptotic challenged cells at all time-points. 
 
Figure 40. Multiplex Real-time RT-PCR for FADD Controls. FADD gene expression (upper 
window) as compared to GAPDH gene expression (lower window). RNA templates 
corresponding to 1, 4 and 12 hour ceramide-treatment time-points. FADD gene expression across 
a dynamic time-course demonstrates little variability in uninfected and non-apoptotic challenged 
cells.
TRADD 
FADD 
86 
 
 
Figure 41. Multiplex Real-time RT-PCR for Caspase-8 Controls. Caspase-8 gene expression 
(upper window) as compared to GAPDH gene expression (lower window). RNA templates 
corresponding to 1, 4 and 12 hour ceramide-treatment time-points. Caspase-8 expression across a 
dynamic time-course demonstrates little variability in uninfected and non-apoptotic challenged 
cells. 
 
 
 
Figure 42. Multiplex Real-time RT-PCR for Caspase-3 Controls. Caspase-3 gene expression 
(upper window) as compared to GAPDH gene expression (lower window). RNA templates were 
generated from uninfected and untreated cells corresponding to 1, 4 and 12 hour ceramide-
treatment time-points. Caspase-3 gene expression across a dynamic time-course demonstrates 
little variability in uninfected and non-apoptotic challenged cells. 
 
Caspase-3 
Caspase-3 
Caspase-8 
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BLAST sequences were used to design 5’-fluorogenic nuclease-assay primer and probe sets using 
Primer ExpressTM software. The target primer and probe sequences were screened for cross-
reactivity using a silica-based system (courtesy of Lawrence Livermore National Laboratories). 
Primer/probe sets were further scrutinized by searching for overlap and self-binding sequences 
using Primer ExpressTM software. Lastly, primer and probe sequences were screened for near 
match “hits” using “NCBI near query”. Primer and probe sequences that pass the software 
vetting, were subject to testing by wet chemistry.  
Each primer probe set was tested for its specificity, sensitivity and overall performance in 
its ability to amplify the target gene. The proper ratio of primer/probe and cation concentration 
ensures that the appropriate start amplification conditions are achieved (Figure 24). Each 
individual primer/probe set may achieve optimal amplification with different cation 
concentrations. Subsequently, the addition of any necessary supplemental components is 
determined (Figure 25). It was previously demonstrated that multiplexed real-time PCR assays 
exhaust reagents when target sequences are present at different molar concentrations. The 
addition of Platinum TaqTM and additional dNTP’s is required for equal amplification efficiency 
for target sequences (personal communication Dr. Jonas Winchell). The addition of supplemental 
yeast tRNA was determined necessary to ensure RNA stability and reproducible data. tRNA acts 
as a chaperone to stabilize RNA template and binds to the walls of plastic vessels ensuring that 
target template is not adsorbed (Sambrook, 1989). 
Further, titration of the primer/probes within the normal range was necessary to determine 
the best minimal concentration without affecting signal intensity (Figure 26). Each gene marker 
was then tested for its amplification efficacy (Figures 27-30). Multiplexed assays allowed for 
assessing apoptotic genes while accounting for overall template concentration (Bustin and 
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Nolans 2004). Properly vetting primer/probe sets allow for selection of the most favorable 
primer/probe set for each target. 
Use of Multiplexed Real-time RT-PCR to Assess Apoptotic Gene Expression 
The major advantage of multiplexing the real-time RT-PCR assay is that it allows for the 
assessment of multiple genes in context with a normalizing house-keeping gene in a single 
reaction tube. Real-time RT-PCR has an added benefit in that it provides visual data for the 
genetic sequence of interest without further manipulation. The dynamics of 5’-fluorogenic 
nuclease chemistry adds an additional stringency to gene expression analysis by requiring two 
primers (both forward and reverse) and a target specific probe. All three independent events are 
necessary for generating a signal event. The lengths of real-time PCR amplicons are much shorter 
than conventional PCR and therefore are inherently less likely to be affected by secondary 
folding of synthesized product. The use of a single normalizing gene allows for relative gene 
expression levels to be measured. However, relative gene expression is only an approximation of 
true gene quantification (Suslov and Steindler, 2005).  
Housekeeping Genes Used for Relative Apoptosis Gene Expression 
Recently, there has been much debate about the use and reliability of conventional house-
keeping genes for the purpose of normalizing gene expression. Some conventional house-
keeping gene targets used for normalizing gene expression are: 18S ribosomal RNA, β-actin, 
RNAase P and GAPDH (Goncalves et al., 2005). Much of this controversy stems from the 
debate over the reliability of gene expression across different cell types (Radonic et al., 2004). 
Gene expression analysis across multiple tissue types does require the use of normalizing genes 
with low variability, but not necessarily robust expression. In addition, the use of multiple 
normalizing genes is essential to properly standardize the basal expression when comparing 
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different cell types (Vandesompele et al., 2002). However, our experimental model is a 
homogenous stable cell line of a single cell type. This provides us genetic stability as opposed to 
primary cells or hybrid cells used in previous research (Kirby and Nekorchuck, 2002). Further, 
our interest focuses on analysis of a cluster of genes with complementary and non-competing 
function. Lastly, we are assessing relative gene expression and not quantitative gene expression.  
Due to the fact that we are using a homogeneous host cell model, the house-keeping gene 
utilized herein provides a good reference for determining our best approximation of gene 
expression. The use of multiplexed real-time RT-PCR has novel value in that we are assessing 
the gene expression of a subset of desired genes between individual test and reference samples 
using small quantities of RNA template derived from a small experimental sample.  
Apoptotic Gene Expression 
What does gene expression highlight about B. henselae’s intracellulat survival strategy? 
When comparing gene expression for TRADD, FADD, Caspase-8 and Caspase-3, there are some 
striking differences for cells that are infected with B. henselae as opposed to cells that are not.  
TRADD expression is induced in a like manner for both ceramide-treated uninfected cells 
(Cer) versus ceramide-treated B. henselae-infected (B+C) cells and Cer versus control (Ctrl) cells 
(Figure 32). TRADD demonstrates a rapid increase in the earliest ceramide treatment timepoints 
(1 and 2 hours), with a rapid decline thereafter, returning to baseline by 6 hours of ceramide 
treatment. In contrast, TRADD gene expression for B+C versus Ctrl is below baseline for all 
treatment time-points. The rapid induction of TRADD demonstrates that TRADD expression is 
induced by the presence of ceramide. The fact that TRADD expression for B+C cells compared 
to controls demonstrates that B. henselae is capable of suppressing TRADD gene expression 
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following ceramide challenge. This is the first account of B. henselae’s ability to suppress the 
synthesis of TNF-1 receptor-death-domain protein following challenge by an apoptogenic agent.  
Unlike TRADD, FADD gene expression maintains a modest ubiquitous expression in 
normal untreated cells. Following ceramide treatment, FADD increases from its normal 
expression level, peaking at 3 hour post-ceramide treatment. FADD expression returns to 
baseline thereafter. FADD expression appears to remain at baseline for B+C versus Ctrl during 
the duration of ceramide treatment. The fold increase in FADD gene expression is most 
impressive when comparing B+C versus Ctrl as compared to Cer versus Ctrl, where it appears 
that the presence of B. henselae suppresses FADD gene expression below that of control cells. 
This agrees with our preliminary finding that Western Blot analysis indicating that untreated 
HMEC-1 cells infected with B. henselae suppress FADD protein expression (Chapter 2, Figure 
7).  
Following our observation that B. henselae infection has a demonstrable effect on 
upstream TNF-dependent apoptosis modulators, we analyzed its effect on down-stream apoptosis 
modulators. Caspase-8 gene expression was induced in a time-dependent manner for both Cer 
versus B+C and Cer versus Ctrl (Figure 36).  However, caspase-8 gene expression was observed 
to be more pronounced in Cer versus Ctrl than for Cer versus B+C. This suggests that 
intracellular B. henselae does suppress caspase-8 but not to levels below that of control cells. 
However, B. henselae does suppress caspase-8 gene expression in the presence of an apoptotic 
challenger.  
Caspase-3 gene expression is consistent for Cer vs Ctrl and Cer vs B+C (Figure 36). 
Caspase-3 gene expression peaks rapidly following ceramide treatment and wanes slowly 
thereafter. The fold-increase of caspase-3 gene expression is modest at less than four-fold. In 
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opposition to caspase-8, caspase-3 does target a multitude of cellular targets and has the most 
abundant cellular pool and a long half-life of approximately 5.5 hours (Tan et al., 2006). The CT 
value of caspase-3 is not significantly lower than that of caspase-8. It does not appear that the 
presence of B. henselae has a dramatic effect on the gene expression of caspase-3, as compared 
to TRADD or FADD. However, considering the cellular reservoir of caspase-3 protein and the 
protein’s half-life, disrupting caspase-3 gene expression may not be an expedient strategy of an 
intracellular pathogen. 
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CONCLUSION 
 
Role of This Study  
In this study, we demonstrated that Bartonella henselae circumvents host cell apoptotic 
mechanisms in order to survive as an intracellular pathogen of endothelial cells. B. henselae aids 
in the survival of their host cells following direct apoptogenic stimuli, thereby aiding their own 
intracellular survival. Previous researchers focused on the ability of B. henselae to stimulate host 
cell proliferation via cellular growth modulators as the means of surviving apoptotic challenge 
(Kempf et al., 2004; Maeno et al., 1999). Others concluded that B. henselae survive by 
abrogation of apoptotic intrinsic pathway proteolytic enzymes to ensure intracellular survival 
(Kirby and Nekorchuk, 2002). Recently, two groups claimed to have found the substrate 
responsible for B. henselae’s ability to disrupt apoptosis (Kempf et al., 2005; Schmid et al., 
2006). Bartonella effector protein-A (BepA) has been described as the substrate that is 
translocated to the host cell where it functions to block apoptosis by increasing cellular cyclic-
AMP (Schmid et al., 2006). However, other research utilizing BadA- B. henselae confirmed that 
Bad A facilitates colonization of B. henselae and contributes a pre-formed effector molecule 
found on both viable and non-viable B. henselae bacterial cells. The presence of this pre-formed 
effector upregulates cellular inhibitor of apoptosis protein (IAP), which is regulated by NF-κB 
(Kempf et al., 2005). 
We assert that B. henselae achieve intracellular survival by redundant measures that 
involve modulation of both extrinsic and intrinsic apoptotic pathways. Preserving host cell 
viability is a consequence of infection with B. henselae, as well as with other related bacteria 
(Conley et al., 1994). However, in contrast to previous research, we noted no significant increase 
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in host cell proliferation due to the presence of B. henselae. It is possible that this effect of B. 
henselae is not apparent within the time-frame of our experimental parameters. In addition, the 
experiments described here did not reveal any effect of intracellular B. henselae upon 
diminishing the cytotoxicity of RIP toxins (e.g., abrin and ricin) which have been shown to 
induce apoptosis by caspase upregulation (Rao, P.V. et. al., 2005). Therefore, we conclude that 
B. henselae is not capable of abrogating all apoptotic mechanisms. Instead, our research results 
suggest that B. henselae exploits divergent apoptosis pathways to survive, such as suppression of 
extrinsic pathway modulators TRADD and FADD, and suppression of intrinsic pathway caspase-
3 enzymatic activity. Bartonella’s tropism for endothelial cells is indicative of its evolution 
toward host cells that are not induced to apoptosis by TNF-α (Faherty and Maurelli, 2008).  
 
Gram-negative Bacterial Infection and LPS 
The innate immune system is able to detect molecular patterns of most pathogens, 
including lipoloysaccharide (LPS) of gram-negative bacteria. The molecular pattern of these non-
mammalian molecules is recognized by Toll-like receptors (TLR) and CD14 (Hansson and 
Edfeldt, 2005). LPS from Gram-negative bacteria bind to TLR-4 and CD14, which ultimately 
leads to the release of IκB from the nuclear factor NFκB. Among the genes activated by NFκB is 
TNF-α. Apoptosis induced by LPS from Escherichia coli in HMEC-1 cells was shown to be 
FADD-dependent. However, neither TNF-R1 nor Fas receptor plays a role in E. coli LPS-
induced apoptosis using HMEC-1 cells (Kyong-Bok et al., 1998). While E. coli LPS, which is a 
potent pyrogen, effectively induces apoptosis in HMEC-1 cells, not all Gram-negative 
endotoxins are apoptogenic.  
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B. henselae possesses an LPS that lacks O-chain carbohydrates, much like other bacteria 
capable of chronic infection such as Legionella spp. and Chlamydia. The result is that Toll-like 
receptors-2 (TLR-2) are not activated and TLR-4 are activated at levels nearly 1000-10,000 fold 
lower than that of other enteric bacteria (Zahringer et al., 2004). Gene expression triggered by 
NF-kB causes ICAM-1 and E-selectin to be upregulated. However, in the case of B. henselae, 
ICAM-1 and E-selectin are upregulated by the presence of a B. henselae synthesized 
proteinaceous factor (Fuhrmann et al., 2001). It has been suggested that the lipid A component of 
LPS can mimic the secondary messenger activity of ceramide. Using a cell permeable analog of 
ceramide, such as C2-ceramide, induces many LPS-inducible genes (Barber et al., 1996; van 
Bitterswijk et al., 2003).  
 
B. henselae Infection 
Nearly a quarter of a century ago, B. henselae was identified as the causative agent of cat-
scratch disease (Wear et al., 1983; Slater et al., 1993). Transmission between cats occurs 
horizontally through the arthropod vector Ctencephalides felis, the cat flea. Cats can maintain 
persistent infections, however, transmission of B. henselae in a cat colony occurs by infection of 
fleas from infected cats, which in turn infect other non-infected cats or re-infect a previously 
infected cat (Breitschwerdt and Kordick, 2000). During the persistent B. henselae infection in 
cats, the bacteria are harbored inside erythrocytes. Nearly 50% of domestic cats are seropositive 
for antibodies to B. henselae. Cat to human infection occurs by exposure to B. henselae-infected 
cat saliva or a scratch from an infected cat (Florin et al., 2008). Upon entering the human host, B. 
henselae invade the hematopoetic progenitor cells but not erythrocytes. B. henselae have been 
shown to infect macrophages (Musso et al., 2001; Kempf et al., 2005) and endothelial progenitor 
95 
cells (Salvatore et al., 2008). This would provide a means for B. henselae to traffic from the site 
of host introduction to their niche in the microvascular endothelium. B. henselae activate NF-κB 
gene products during the course of binding to the endothelial cell membrane and the formation of 
the invasome, a set of membrane protrusions that engulf the bacteria (Dehio et al., 1999). 
However, invasome formation is found in umbilical vein endothelial cells such as HUVEC and 
not microvascular cells (Dehio, 2004). Upon entry into the microvascular endothelium, B. 
henselae induce the upregulation of cellular inhibitors of apoptosis (cIAP-1 and -2) and cellular 
adhesion molecule genes, ELAM-1 and ICAM-1 (Faherty and Maurelli, 2008). 
 
Bartonella Protein Factors and Their Role in Intracellular Survival 
Bartonella possess a variety of genes that are analogous to pathogenicity factors used by 
other bacteria that survive intracellularly in a similar manner (Foulongue et al., 2000). Some of 
the proteins derived from these pathogenicity genes are used in an analogous manner to B. 
henselae to ensure its survival (Hacker and Fischer, 2002). The VirB/D4 gene cluster was 
discovered in Bartonella spp. following the identification of a 17kDa antigen with sequence 
similarity to the virB7 gene of Agrobacterium tumefaciens (Padmalayam et al., 2000). Many of 
the virulence properties of B. henselae, such as their entry into erythrocytic cells and their ability 
to promote cytoskeleton and adhesion molecule rearrangement (Schulein et al., 2002), can be 
ascribed to the expression of the VirB/D4 operon, which codes for a Type IV secretion system 
(T4SS)(O’Callahan, et al., 1999). The induced operon functions to transfer Bartonella 
translocated effector proteins (Bep A-G) into the host cells. BepA has been proposed to have 
anti-apoptosis activity. Both BepA and BepD have also been proposed to have angiogenic 
activity, while BepG has been assigned an anti-angiogenic role (Molloy, 2009; Scheidegger et 
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al., 2009 ). BepA protein has been shown to translocate to the host cell membrane and increase 
the cyclic adenosine monophosphate (cAMP) levels in the cell. cAMP then activates a variety of 
protein kinases (PKA, ERK and MAPK) and inhibits the pro-apoptotic protein Bad. T4SS 
substrates with similar function have been identified in other bacterial systems (Couturier et al., 
2006).  
Although BepA appears to play a significant role as an anti-apoptotic factor, it is unlikely 
that the BepA-induced pathway is the only mechanism used by B. henselae to prevent apoptosis 
of their host. In many cases, pathogens have evolved redundant strategies to ensure their survival. 
One example involves the F1 Yersinia antigen. Yersinia survival strategies and pathogenic 
factors bear many similarities to those of Bartonella spp. and other intracellular bacteria (de Jong 
et al., 2008). For many years, the F1 antigen has been considered to be the primary (and perhaps 
only) factor necessary for Yersinia pestis pathogenesis. However, the recent isolation of virulent 
F1 negative clinical isolates suggests that Y. pestis has other pathways available for maintaining 
virulence (Bashaw et al., 2007; Dr. Jeanine Petersen CDC, Fort Collins, CO personnal 
communication).  
The B. henselae outer membrane protein adhesin A (BadA) has been identified as a 
Bartonella pathogenicity factor required for pathogen and host cell interaction (Reiss et al., 
2004). BadA is a non-fimbrial adhesion protein similar to its Yersinia counterpart YadA 
(Monack et al., 1997). BadA appears to play a role in initiating an angiogenic response in host 
cells and inhibiting phagocytosis. However, a variant of the strain used for our studies (Houston-
1: ATCC 49882) lacks expression of BadA and yet is capable of adhesion and entry into 
endothelial cells (Reiss et al., 2004). While the search for the conclusive pathogenicity factor of a 
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particular pathogen is appealing, the reality is more likely to be that infectious agents have 
devised a versatile repertoire in order to successfully survive (Rajashekara et al., 2005).  
 
B. henselae Disrupts Gene and Protein Expression of Extrinsic and Intrinsic Apoptotic 
Pathway Modulators Following Apoptogenic Ceramide Treatment 
Our research has demonstrated that B. henselae targets apoptosis basically from the 
outside in. In short, B. henselae is capable of disrupting apoptotic modulators that function 
earlier in the cellular apoptotic pathway chain. Specifically, TRADD and FADD gene and protein 
expression are disrupted by the presence of B. henselae. Past researchers have largely focused on 
the enhanced proliferative activity of B. henselae factors as the mode of anti-apoptotic activity 
(Kempf et al., 2001). Our studies differ in several ways. First, we used an experimental model 
and growth conditions that are consistent with natural disease and maintain the integrity of 
microvascular endothelial characteristics.  In addition, we challenged the host cells with an 
apoptogenic agent that mimics a natural cellular messenger in response to Gram-negative 
bacteria. 
We contend that serum starvation or protein synthesis inhibition (methods used by other 
investigators to induce apoptosis) adds an unnecessary bias by suppressing protein synthesis. The 
lack of serum simultaneously activates and suppresses multiple pathways and many of these 
mechanisms are poorly understood. Further, low serum concentration causes HMEC-1 cells to 
lose their microvascular endothelial characteristics (Ades et al., 1992). Protein synthesis 
inhibitors provide two divergent biases. First, the lack of protein synthesis prevents any apoptotic 
or anti-apoptotic gene product which lacks sufficient cytoplasmic pools from being generated. 
This is not consistent with primary mechanisms of the natural disease state or the host immune 
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response. Secondly, previous researchers have demonstrated that protein synthesis inhibition 
disrupts the balance between typical caspase and c-FLIP proteins (Zimmermann et al., 2001). 
Two apoptogenic agents which indeed disrupt protein synthesis, ricin toxin and abrin toxin, were 
tested in our model. The apoptogenic effect of these two agents on the host microvascular 
endothelial cell was not disrupted by the presence of B. henselae (data not shown). 
 The use of ceramide affords us an apoptogenic agent that mimics the cellular response to 
Gram-negative LPS (van Bitterswijk et al., 2003).  Ceramide has been characterized as causing 
induction of cellular kinases which leads to caspase induction in several experimental models. In 
fact, ceramide functions in at least four areas of the cell during apoptosis signaling.  In the Golgi, 
ceramide contributes to lipid metabolism which helps generate lipid rafts (van Blitterswijk et al., 
2003). At the cell membrane, ceramide facilitates receptor clustering (Gulbins et al., 2004), and 
alters mitochondria permeability (Kolsenick, 2002; Siskind et al., 2002). Ceramide also 
contributes to the formation of membrane bound apoptotic bodies (van Blitterswijk et al., 2003). 
Ceramide is released endogenously following extracellular stresses, such as treatment with 
lipopolysaccharide (LPS). However, we confirmed what others have observed that, B. henselae 
LPS is not cytotoxic by comparing the cytotoxic effect of like concentrations of endotoxin 
derived from both B. henselae and E. coli (Zahringer et al., 2004).  We have demonstrated that 
endothelial cells respond to exogenous ceramide in a dose-dependent apoptotic response. 
 
B. henselae Disrupts Extrinsic Pathway Receptor Mediated Apoptosis in Order to Ensure 
Its Survival 
TNF-receptor-1 (TNF-R1) clustering induces recruitment of TRADD to the TNF-R1 
death domains (DD). This occurs in response to TNF-α-induced receptor clustering or lipid raft 
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induced clustering. In endothelial cells, the endogenous release of TNF-α would not necessarily 
signal theTNF-R1 clustering that would be expected to result in DISC formation. However, the 
addition of exogenous ceramide is known to result in lipid raft formation and the clustering of 
receptor proteins (Cuschieri et al., 2006; Gulbins et al., 2003). The clustering of TNF-R1 by 
ceramide would induce DISC formation, resulting in the accumulation of TRADD at the TNF-R1 
DD. The recruited TRADD would recruit necessary downstream modulators (e.g., FADD). The 
rapid rise and fall of TRADD gene expression for ceramide treated endothelial cells would 
indicate that either 1) TRADD is stable and does not require prolonged translation,or 2) as the 
uninfected cell succumbs to ceramide treatment, the cell is diverting valuable resources to the 
production of new TRADD proteins. Infection by B. henselae precipitously suppresses both gene 
and protein induction of TRADD, indicating that there is a strong correlation between the 
presence of the bacteria and the signal(s) that trigger TRADD induction. By suppressing TRADD 
gene expression, B. henselae could cut off the cascade of events associated with the TNF-R1 
extrinsic apoptosis pathways.  
TRADD and FADD are sequential cellular modulators recruited by TNF-R1 in the TNF-
dependent pathway. FADD recruitment has already been demonstrated to induce endothelial cell 
apoptosis specifically in HMEC-1 cells (Kyong-Bok et al., 1998).  As mentioned previously, our 
early observation that FADD protein expression declines following B. henselae infection 
suggested a preemptive and continuous anti-apoptotic strategy by B. henselae. It is important to 
remember the loss of detectable FADD by Western Blot following infection of B. henselae 
(Figure 7) occurred in the absence of any apoptosis agonist. The overall purpose of FADD in 
extrinsic pathway apoptosis is the recruitment of other downstream apoptotic modulators, namely 
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caspase-8, to the DISC. FADD is recruited by both TRADD and Fas as part of extrinsic apoptotic 
signaling pathways.  
When examining gene expression as fold-increase, it is important to point out that 
expression levels are based on which sample type is being used as the benchmark and which is 
used as the illustration. Gene expression for TRADD is profoundly induced by ceramide. This is 
potentiated by the fact that the presence of B. henselae suppresses TRADD gene expression. 
FADD gene expression is only modestly induced by ceramide. B. henselae-infected cells 
suppress FADD gene expression, which makes FADD appear as a highly inducible gene 
following ceramide treatment. A different picture emerges when analyzing TRADD and FADD 
protein expression. TRADD protein expression is clearly inducible and is suppressed by the 
presence of B. henselae. The percentage of cells expressing TRADD is nearly 3 times lower in B. 
henselae-infected cells. Conversely, FADD protein is expressed in nearly half the cells regardless 
of B. henselae’s presence. But the presence of B. henselae does keep FADD expression from 
going any higher and slightly suppresses FADD protein expression. We demonstrated that B. 
henselae affects FADD protein expression both during the course of infection or following 
apoptogenic stimuli of B. henselae-infected cells. What is more pronounced is the profound 
effect B. henselae has on the gene and protein expression of TRADD. By abrogating TRADD 
signaling, B. henselae has subverted initiation of an entire apoptotic pathway.   
 
B. henselae Suppresses Caspase-3   
Previous studies have indicated that Bartonella-infected cells suppress apoptosis 
induction by abrogating caspase activity (Kirby et al., 2002). Our data indicate that B. henselae is 
capable of suppressing caspase-3 activity and caspase-8 and -3 gene expression. But the loss of 
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caspase-8 activity was not observed within our experimental parameters. Caspase-8 is the initial 
cysteine protease messenger in extrinsic (TNF-receptor-1 and Fas-dependent) apoptotic signaling 
pathways. Pools of capase-8 are maintained in the endoplasmic reticulum and translocated to the 
DISC complex following receptor signaling (Homlstrom et al., 2000). As an initiator of the 
caspase cascade, caspase-8 present at high levels is not sufficient, nor required, to sustain 
apoptotic induction (Green, 2003). As an executioner, caspase-3 proteolytically cleaves many 
cellular substrates. Additionally, caspase-3 is necessary as an executioner for both intrinsic and 
extrinsic apoptotic pathways.  This would require that either large pools of caspase-3 are 
maintained, or that caspase-3 is a rapidly inducible gene product. As mentioned earlier, caspase-3 
is the most abundant caspase in the cell (Chickova et al., 2004).  
It is worthy to note the inherent flaws in relying upon caspase proteolytic activity assays 
as a true measurement of caspase involvement. First, the caspase specific target peptides are not 
actually specific, but rather preferential for a particular caspase. Second, enzymatic activity may 
not be an accurate measurement of a specific caspase activity. Historic dogma asserts that 
caspases are synthesized in a proform. The active “enzymatic” form is generated following 
proteolytic cleavage. Recent studies refute that assertion, especially with regard to caspase-8. 
Caspase-8 is active in its dimeric form (Green, 2003; Thorburn et al., 2004). As mentioned 
earlier, caspase-8 has been shown to be “enzymatically” active in an unprocessed form. Thus, 
unprocessed caspase-8 may facilitate auto-proteolysis of caspase-3. Unlike caspase-8 and 
possibly caspase-6, caspase-3 is primarily a proteolytic enzyme.  
What is clear is that ceramide treatment causes activation of caspase-3. Ceramide-induced 
activation of caspase-3 for uninfected cells occurs earlier, is maintained for a longer duration and 
is significantly more active as compared to ceramide treated B. henselae-infected, or control 
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cells. Our observation that caspase-3 is the only caspase of those we tested that is suppressed by 
the presence of Bartonella species is in direct conflict with previous observations (Kirby and 
Nekorchuck, 2002; Schmid et al., 2006). We believe this is in part due to the cell line model 
used. Cell type variability in the use of different apoptosis mechanisms is an obstacle when 
comparing results using different model systems. Additionally, the use of an apoptogenic agent 
may produce different results than the use of serum starvation as the apoptogenic stimulus. 
 
Summary 
What we know about the strategies used by B. henselae to maintain host cells in numbers 
sufficient for successful infection is multifaceted. Previous research has demonstrated that B. 
henselae enhances proliferation (Slater et al., 1994; Maeno et al., 1999), that the cell 
cytoskeleton is rearranged during the course of infection (Dehio, 1999) and that adhesion 
molecules are upregulated that enhance B. henselae internalization (Fuhrmann et al., 2001). 
Additionally, unlike those of other Gram-negative bacteria, the LPS molecules of B. henselae are 
not capable of inducing apoptosis (Zahringer et al., 2004). The VirB/D4 operon provides a 
transport pilus that acts to translocate effector proteins, such as BepA, which are capable of 
“subverting” the host cell apoptosis mechanisms. Moreover, B. henselae generated modulators 
can affect caspase activity and thereby influence the cells’ decision to enter an apoptotic pathway 
(Schmid et al., 2006).  
Our research provides evidence that B. henselae disrupts host cell gene and protein 
expression of the extrinsic apoptosis modulators TRADD and FADD. TRADD gene expression 
in particular is significantly suppressed by the presence of B. henselae.  B. henselae also 
suppresses FADD gene expression. FADD protein is ubiquitously expressed under normal 
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cellular growth conditions. However, the presence of B. henselae minimizes FADD protein 
expression even following prolonged apoptogenic stimuli. In our experimental system caspase-8 
and caspase-3 gene expression were modestly suppressed by B. henselae.  
The proteolytic activity of either caspase-8 or caspase-6 was unaffected by the presence of 
B. henselae. However, the proteolytic activity of caspase-3 was suppressed significantly B. 
henselae. In fact, at some ceramide treatment time-points, B. henselae-infected cells had higher 
caspase-6 and caspase-8 activity than their uninfected counterparts. Lastly, the formation of 
apoptotic bodies and DNA fragmentation was dramatically reduced in B. henselae-infected cells. 
Enhanced host cell viability for B. henselae-infected cells was consistent with these results. We 
do know that B. henselae cannot disrupt the apoptogenic action of all apoptogenic stimuli, such 
as ricin and abrin toxins.  
 
Future Directions  
The means by which B. henselae migrate from their point of entry to their niche in the 
microvascular endothelium is not understood. Furthermore, the cellular proteins targeted by 
translocated effectors upon entry by the bacterium into the microvascular endothelium remain to 
be identified. Only a handful of apoptogenic agents have been used to challenge Bartonella spp; 
Hundreds of natural apoptogenic agents remain untested. Still, elucidation of the mechanism(s) 
by which B. henselae ensures its survival will enhance our understanding of pathogen-induced 
tumorgenesis. It will also help us to understand the processes used by evolutionarily similar 
intracellular bacterial pathogens.  
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